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Waterborne pathogens are a global health concern, with 1 billion people having no 
access to uncontaminated water sources and 2.2 million annual deaths resulting from 
infection. Biosensors offer the possibility of rapid, sensitive and specific detection of 
pathogens and, thus, the ability to provide warning systems prior to consumption and a 
means to monitor the efficacy of disinfection systems. However, in order for 
biosensors to be useful, one must be able to attain clinically relevant detection limits in 
real environmental samples and do so on a reasonable timescale. Thus, methods to 
increase the analytical sensitivity via pre-concentration and microfluidic device design 
are described herein. Firstly, employing a series of pre-concentration and purification 
steps followed by an enzymatic amplification of an mRNA sequence, it is shown that a 
limit of detection of one Cryptosporidium parvum oocyst can be attained and that this 
assay does work in real water samples. Secondly, integrating a liposome-based 
immunoassay and a nanoporous membrane for electrokinetic pre-concentration into a 
single microfluidic device for the detection of a human norovirus surrogate yielded an 
order-of-magnitude decrease in the limit of detection when compared to an optimized 
device foregoing pre-concentration. Finally, the optimization of microfluidic channel 
dimensions for assays using liposomal signal amplification is described; illustrating 
that a 60% reduction in channel height produces an order-of-magnitude reduction in 
the limit of detection. Taken together, the described work provides tools to advance 
the field of biosensors by demonstrating means to improve analytical sensitivity and 
overcome the obstacles presented by environmental water samples. 
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CHAPTER 1 
BIOSENSORS FOR THE DETECTION OF WATERBORNE PATHOGENS 
Abstract 
Waterborne bacterial, viral and parasitic pathogens are a global health concern and 
their rapid and specific detection in contaminated potable water is of utmost 
importance. Biosensors have been reported employing various biorecognition 
molecules and transduction methodologies as they have promise to provide highly 
sensitive detection of the analyte of interest in a short time frame and a high degree of 
specificity. However, there are several obstacles to the detection of waterborne 
pathogens; namely they tend to be present at very low concentrations in the 
environment and environmental samples contain numerous inhibitors of enzymatic 
reactions and interfering organisms and particulates. Here we present a review of the 
current state of biosensor technology with respect to the needed improvements over 
standard detection methods and the challenges presented by real environmental 
samples. Further, we identify future areas of focus necessary to realize novel detection 
devices capable of supplanting the gold standards of today. 
Importance and challenge of waterborne pathogens 
Lack of access to safe, potable water is a global health concern that, in combination 
with poor hygiene and sanitation facilities, impacts more than half the population of 
the developing world. Almost 1 billion people rely on contaminated water sources, 
contributing to the 2.2 million annual deaths caused by diarrheal diseases (1), which 
the World Health Organization (WHO) estimates as at least 4% of the global disease 
 2   
burden (2). This lack of access to safe water and proper sanitation facilities 
disproportionately effects children; those under 5-years-old account for over 90% of 
the annual deaths from diarrheal diseases with about 5,000 children dying per day (3). 
Table 1.1: World Health Organization (WHO) List of Relevant Waterborne Pathogens
†
  
 
 
Waterborne pathogens are also a problem in developed nations. The annual number of 
cases of acute gastrointestinal illness in the United States caused by the consumption 
of contaminated water has been estimated to be from 4.26 million (4) to as high as 
Pathogen Associated Disease
Relative 
Infectivity
Persistence in 
water
Resistance to 
Disinfection
Bacteria
Burkholderia pseudomallei melioidosis Low May multiply Low
Campylobacter jejuni , C. coli gastroenteritis Moderate Moderate Low
Escherichia coli  - pathogenic gastroenteritis Low Moderate Low
E. coli O157:H7 (enterohaemorrhagic) gastroenteritis, hemolytic-uremia High Moderate Low
Legionella spp. Legionnaires' disease Moderate May multiply Low
Non-tuberculous mycobacteria Pulmonary disease, skin infection Low May multiply High
Pseudomonas aeruginosa Pulmonary disease, skin infection‡ Low May multiply Moderate
Salmonella Typhi Typhoid Fever Low Moderate Low
Salmonella enterica Salmonellosis Low May multiply Low
Shigella spp. Shigellosis High Short Low
Vibrio cholerae Cholera Low Bioaccumulates Low
Yersinia enterocolitica gastroenteritis Low Long Low
Viruses
Adenoviruses gastroenteritis, respiratory infection High Long Moderate
Enteroviruses gastroenteritis High Long Moderate
poliovirus poliomyelitis High Long Moderate
coxsackievirus meningitis High Long Moderate
Astroviruses gastroenteritis High Long Moderate
Hepatitis viruses A,E Hepatitis High Long Moderate
Noroviruses gastroenteritis High Long Moderate
Sapoviruses gastroenteritis High Long Moderate
Rotavirus gastroenteritis High Long Moderate
Protozoa
Acanthamoeba  spp. keratitis, encephalitis High May multiply Low
Cryptosporidium  spp. Cryptosporidiosis High Long High
Cyclospora cayetanensis gastroenteritis High Long High
Entamoeba histolytica amoebic dysentery High Moderate High
Giardia lamblia Giardiasis (Beaver fever) High Moderate High
Naegleria fowleri Primary amoebic meningoencephalitis Moderate May multiply Low
Toxoplasma gondii Toxoplasmosis High Long High
Helminths
Dracunculus medinensis Dracunculiasis (Guinea worm disease) High Moderate Moderate
Schistosoma  spp. Schistosomiasis High Short Moderate
‡ immunocomprised individuals
† Adapted from WHO Guidelines for Drinking Water Quality (10)
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32.9 million (5). Some of the largest outbreaks resulting from protozoan parasites, like 
Cryptosporidium and Giardia, have been in developed nations. The 1993 outbreak in 
Milwaukee, Wisconsin, is still the largest caused by Cryptosporidium; over 400,000 
people were infected and 100 deaths were attributed to the contamination of the 
municipal water supply (6, 7). A crisis hit Sydney, Australia, in 1998 when severe 
weather systems flooded the water treatment facilities with Cryptosporidium oocysts 
and Giardia cysts that were ultimately detected in filtered water triggering 70 days of 
boil water alerts (8). In Western Europe, higher hygiene standards have lead to 
decreased immunity to enteric viruses, like hepatitis A, causing a spike in cases (9). 
 
The causative agents of most waterborne diseases can be divided into three categories: 
bacteria, viruses, and parasites, the latter consisting of protozoan and helminths. Those 
of greatest concern, shown in Table 1.1 adapted from the WHO (10), are those that are 
capable of causing severe disease and persist in the environment for a long time and 
can withstand common disinfection methods, either due to a resistant state such as a 
spore or vegetative phase for bacteria, the cysts, oocysts and ova of parasites and most 
viruses. In all cases, infected people and animals shed large numbers of microbes in 
feces, which can then directly contaminate water supplies through untreated or 
undertreated sewage or through accidental release. Additionally, the practice of using 
livestock waste for fertilization can result in contamination of reservoirs and wells via 
runoff or permeation into the groundwater as well (11). As a result, some countries are 
considering restrictions on this practice based on pathogenic content modeled after 
current US EPA rules (12). The use of untreated wastewater for irrigation of crops, 
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particularly those consumed raw, can also result in exposure to pathogens and 
infection (13). Contamination of marine environments can result in the 
bioaccumulation of bacteria, like Vibrio cholerae (6), and viruses in shellfish (11, 14). 
Many of these microbes remain infective for long periods in aqueous environments, 
allowing them to travel long distances from the initial source (15). In this regard, 
viruses are of utmost concern. Their longevity permit them to contaminate deep 
aquifers - water sources long thought to be untouched by microbes and thus, safe and 
pure (16). As waterborne pathogens travel through the environment they are typically 
diluted to low, but clinically concerning, concentrations creating a detection challenge. 
Indicator organisms 
In 1989, the United States Environmental Protection Agency (US EPA) established 
rules for water quality monitoring, setting benchmarks, limiting the potential risk of 
infection to no more than 1 in 10,000 per year (17), that have served as a guideline for 
regulation in other countries (18). The cornerstone of these regulations is the 
monitoring of total coliform bacteria in source and finished water to assess 
disinfection efficiency and trigger further testing for specific pathogens (19). Coliform 
bacteria include bacteria that are typically found in feces, collectively called fecal 
coliform, such as Escherichia coli, Enterococcus spp. and Clostridium perfringens, 
and is, therefore, an indicator for fecal contamination, which in turn is an indicator of 
the potential for pathogenic microbes (20). This method is flawed as significant 
pathogens persist in water far longer than coliform bacteria, namely enteric viruses, 
which can be found in low concentrations in samples showing no other sign of fecal 
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contamination. Due to this, some non-pathogenic viruses have been evaluated as 
indicators of contamination or to aid in the assessment of disinfection techniques (20, 
21). The use of these indicator organisms remains the gold-standard of monitoring and 
regulation due to the prohibitive cost of testing for multiple, individual pathogens 
spanning a diverse array of microbe types. 
Standard techniques for waterborne pathogen detection 
Detection for bacteria, both fecal indicators and pathogens, and viruses are dominated 
by culture techniques and molecular biology methods. For bacterial detection, 
standard bacterial cell culture methods are employed and the presence of bacterial 
growth can be measured via the development of colonies that may be counted, for 
plated cultures (22, 23). Similarly, the presence of viral pathogens can often be 
determined via cell culture plaque assays. Here, a sample is added to a monolayer of 
mammalian cells that is then fixed in agar. The plates are then observed for plaques, 
regions of dead cells exhibiting cytopathogenic effects (CPE) (24). Culture methods 
are time consuming, bacteria can take days to grow (25) while some viruses can take 
several weeks to develop plaques. Some viruses will never form plaques as they are 
very slow growing, do not produce CPE, or no cell lines have been determined on 
which they grow (26). More rapid methods for coliform bacteria have been developed, 
marketed as Colilert® and Colisure®, that rely on chromogenic substrates added to 
culture media that yield a visible color change as it is cleaved by bacterial enzymes 
(27). 
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Immunological methods, such as serum neutralization tests (SNT), 
immunofluorescence, and Enzyme-Linked Immunosorbent Assays (ELISA) have been 
used for detection of waterborne pathogens. SNT is used for the serotyping of viruses 
and calls for mixing a sample, extracted from a plaque assay, with antiserum and then 
assessing the decrease of infectivity by plaque assay (28). These tests are extremely 
time consuming as they require two rounds of cell culture. Immunofluorescence 
assays for viruses allow for a shortening of assay time compared to SNT as it 
eliminates the second round of cell culture and employs fluorophore-labeled 
antibodies for detection via microscopy (29) or flow cytometry (30). Assays based on 
immunofluorescence and immunomagnetic separation (IMS) are the gold standard for 
the detection of protozoan parasites. The US EPA have established methods 1623 for 
the combined detection of Cryptosporidium spp. and Giardia spp. (31), or 1622 for 
Cryptosporidium spp. alone (32), both of which employ IMS followed by 
immunostaining and fluorescent microscopy. ELISA has been used for the detection 
of waterborne pathogens (33, 34), but has not been as popular for environmental 
samples as in clinical analyses (35). Immunological methods suffer from the inability 
to determine infectivity, as living and dead organisms appear the same, and in addition 
are very time-consuming. 
 
Since it was first published in 1988, the Polymerase Chain-Reaction (PCR) (36), and 
modifications like reverse transcriptase PCR (RT-PCR), real-time, quantitative, 
nested, and multiplex PCR (37-42), have become indispensible tools for the detection 
and identification of pathogens. Other techniques, such as Nucleic Acid Sequence-
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Based Amplification (NASBA), have also been used for assays to detect waterborne 
pathogens (43-46). When compared to cell culture, molecular techniques are far more 
appealing due to the shorter time to result, typically no more than a few hours as 
opposed to days or weeks, as well as increased sensitivity (37). Also, by allowing for 
the detection of sequences specific to only the pathogen of interest, molecular 
biological techniques create a level of discrimination unavailable in cell culture. 
However, particularly with respect to viruses, these methods do not provide 
information on the infectivity of the pathogen being detected. 
Biosensors as novel detection methods 
Biosensors are devices or assays that employ a biorecognition element coupled to a 
signal transducer to detect an analyte of interest (47). Common biorecognition 
elements include oligonucleotide probes, antibodies, aptamers, cell surface molecules 
(48), and phages (49). Transduction methodologies can be roughly divided into three 
primary types: optical, electrochemical and mechanical. Biosensors offer the promise 
of substantial improvements over the standard methods and have been reported 
employing the full spectrum of biorecognition molecules and transduction methods for 
the detection of waterborne pathogens, with oligonucleotide probes and antibodies 
being the most common.  
Criteria for biosensors development 
New detection methods for waterborne pathogens must be superior to the current 
standards in one or more of three key characteristics: sensitivity, specificity, and 
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speed. Also important, though secondary to these three areas, are reductions in the 
susceptibility of the method to user error and the portability of the biosensor.  
 
Sensitivity, in most cases, is defined as the ability to detect very few organisms in a 
sample (rather than the degree of discrimination between various concentration 
levels). How sensitive an assay must be is dependent on the specific pathogen’s ability 
to cause disease as well as governmental regulations and regulatory goals. For 
instance, as few as 10 viable C. parvum oocysts can cause infection in healthy adults 
(50) and the US EPA regulatory goal is the complete absence of these oocysts from 
finished drinking water (17). Therefore, an effective new analytical method must meet 
this goal and be capable of detecting a single viable oocyst.  
 
New methods can also seek to improve the specificity of detection with respect to 
discerning one closely related species from another or even viable organisms from 
dead. Some standard methods are very effective with respect to these two criteria. For 
example, cell culture methods can be used to detect a single CFU or PFU and 
inherently provide discrimination with respect to viability status. US EPA method 
1622 can easily detect 10 Cryptosporidium spp. oocyst (51), but cannot discriminate 
between pathogenic and non-pathogenic species or viable and dead oocysts without 
additional analytical steps such as staining. Further, all of these methods fail with 
respect to the third criterion, providing rapid results.     
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Novel methods can, do, and will make trade-offs with respect to these key areas as do 
the standard methods. In developing a new assay these trade-offs are inherent in the 
selection of the detection methodology, especially between molecular biological and 
immunological. Molecular biological methods are often sensitive enough to detect a 
single organism but can sacrifice speed as they require time for the enzymatic 
amplification of the nucleic acid target and the processing of the sample in order to 
access the genetic material of the organism. For example, Taniuchi et al. reported a 
multiplex PCR reaction for protozoan parasites using Luminex® beads with limits of 
detection of 10
2
 Cryptosporidium spp. oocysts, 10
3
 Giardia lamblia cysts and 10
1 
Entamoeba histolytica trophozoites (52). However, the assay includes an extensive 
DNA purification procedure requiring well over an hour to complete. Immunological 
assays tend to be faster, as less sample pre-processing is required, but can sacrifice 
sensitivity. The lower limits of detection of immunoassays range from 10
3
 to 10
6
 cells, 
cysts, oocysts or CFU per mL, but can yield results in as little as 10 minutes(53-59). 
Both methodologies can have high levels of specificity. However, the specificity of 
antibody-based detection is highly dependent on the availability of quality antibodies 
whereas nucleic acid amplification requires the ability to identify a unique sequence in 
the genome of the organism of interest and designing suitable primers and probes.  
Obstacles to detection 
Environmental samples pose a number of challenges to assay development due to the 
numerous potential microbial, particulate, and other organic and inorganic 
contaminants. Also, as previously stated, waterborne pathogens, especially those that 
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persist for long times, are typically present at low concentrations in environmental 
samples, itself an obstacle to detection. Taken together, these present a formidable 
hurdle to overcome; thus, sample pre-treatment that is compatible with the selected 
method of detection must be considered when comparing the relative merits of two 
assays and included in the development of a novel method.  
 
The current standard for sample filtration and concentration is commercially-available 
charged membrane filters through which large volumes of water can be processed and 
various buffer changes are required for the adsorption and elution of the analyte of 
interest (33, 42, 60). Microfluidic devices for pre-processing have been developed 
exploiting similar principles.  Balasubramanian et al. took advantage of the net surface 
charge of waterborne microbes in the development of a microfluidic electrostatic 
trapping device, consisting of a microchannel with electrodes as two of the walls, 
capable of concentrating E. coli, Salmonella and Pseudomonas with over 99% capture 
efficiencies (61). 
 
Size-based microfluidic filtration techniques have also been implemented for pre-
concentration. Taguchi et al. fabricated a stainless steel filter with conical pores 
integrated into a microfluidic device. Under negative pressure, a sample is pulled 
through the pores and larger particles are captured and the analyte of interest, here C. 
parvum oocysts, can be visualized and quantified using fluorophore-conjugated 
antibodies (62). Microfluidic devices using electrokinesis and in situ 
photopolymerized nanoporous membranes have been demonstrated for concentration 
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of analytes (63)while allowing for removal of smaller competing molecules (64). 
Similar membranes have been combined into a single microfluidic device with 
downstream liposome-based detection in an immunoassay for a human norovirus 
surrogate, yielding an order of magnitude improvement in the analytical sensitivity 
(65). Implementing a device replicating a macro-scale weir, Zhu et al. captured C. 
parvum oocysts or G. lamblia cysts where the channel depth dramatically reduces, 
again allowing for detection via immunofluorescence (66).  
 
Filtration methods are particularly useful when processing large sample volumes – on 
the scale of liters – and provide the much needed initial purification necessary when 
handling environmental samples. However, filtration cannot provide the specificity of 
IMS, which has become an invaluable tool for both concentrating the analyte of 
interest and purifying the sample solution. The latter is of particular interest as 
environmental samples often contain organic and inorganic compounds that can act as 
inhibitors of the enzymes required for molecular amplification techniques (67). As 
magnetic particles are available in a range of sizes, IMS is also appealing for 
implementation in micro-total analysis systems. Microfluidic devices employing IMS 
prior to PCR-based detection have been reported for E. coli O157:H7, with a detection 
limit of 0.2 CFU/µL (68) and 10
2
 PFU/mL enterovirus 71 (38, 39). Foregoing 
magnetic beads and directly immobilizing the capture antibodies inside of a 
microchannel, which can minimize user error, Dharmasiri et al. reported a device 
capable of detecting only 6 CFU E. coli O157:H7 (69). The use of IMS and other 
antibody-capture techniques as a pre-processing step in molecular biology-based 
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assays very clearly elucidates why immunoassays can be dramatically faster. Figure 
1.1 compares the typical process flow for immunoassays and DNA biosensors 
employing common signal transduction techniques. Detection of nucleic acid 
sequences requires 2 to 3 additional pre-processing steps after immunoseparation, 
whereas the introduction of a second, labeled antibody creates the sandwich 
immunoassay commonly used with various detection platforms (59, 70-73).  
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Future improvements for waterborne pathogen immunosensors 
 
Key to the future potential of immunoassays for waterborne pathogens is the increase 
of the analytical sensitivity to levels more in line with the detection limits required to 
meet public health and water safety goals. Lower limits paired with the already short 
time to results would make these biosensors indispensable. To achieve these increases 
in analytical sensitivity, methods for the amplification of specific signals and 
reduction of the background noise must be investigated. 
 
Signal amplification employing enzyme-labels, as in traditional ELISAs, is well 
established in biosensors (53).  However, as this amplification is reliant on the 
enzyme’s action on a provided substrate over time, this method is less desirable. 
Liposome nanovesicles encapsulating a fluorescent dye, employed as a marker, have 
been demonstrated to provide substantial, instantaneous signal amplification and high 
sensitivity compared to single fluorophore labels (74). Biosensor immunoassays using 
liposomes for the detection of whole E. coli O157:H7 have shown the benefit of 
liposome lysis for increasing the analytical sensitivity; intact liposomes produced a 
limit of detection of 10
3
 CFU/mL (75), while lysed liposomes produced readable 
signals for 1 CFU/mL (76). As liposomes can encapsulate a range of water soluble 
molecules, they can be used for signal amplification with other transduction 
techniques, such as electrochemical detection (77, 78).  
 
Exploring other transduction techniques for a wide range of signal amplification 
strategies can be chosen. For example, using a portable surface plasmon resonance 
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(SPR) system, Soelberg et al. employed antibody-labeled magnetic beads to produce 
an 80-fold amplification of the signal in an assay for a microbial enterotoxin (70). 
Here, as the change in the measured refractive index in SPR biosensors is relative to 
the size of particles binding to the surface, signal amplification can be produced 
simply with a large particle. Similarly, the increase in mass provided by gold 
nanoparticle labels has been used to produce signal amplification leading to four 
orders-of-magnitude improvement in sensitivity for surface acoustic wave biosensors 
(79, 80). 
 
An interesting methodology for enhanced sensitivity is the integrating waveguide 
biosensor. Here, antibodies immobilized on the interior surface of a glass capillary 
tube and those conjugated to a fluorophore bind the pathogen of interest. Light is 
incident normal to the capillary for excitation while emitted light couples into the 
capillary waveguide and is collected by a photomultiplier tube (PMT). In this format, 
the sensitivity is enhanced as the specific signal increases with the length of the 
capillary while the background noise remains the same, yielding a two orders-of-
magnitude decrease in detection limit compared to fiber optic biosensors (81). Zhu et 
al. showed the integrating waveguide biosensor could detect as few as 10 cells of E. 
coli O157 per capillary (82), corresponding to a concentration of about 10
2
 CFU/mL.  
 
The integrating waveguide biosensor elucidates that importance of not only signal 
amplification but the reduction of background noise. Though in that system the noise 
simply does not increase, the development of systems that reduce the contribution 
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noise can reduce detection limits by increasing the signal-to-noise ratio. Biosensors 
that take advantage of the evanescent wave generated by total internal reflectance of 
light confined within an optical fiber or waveguide, allows for the specific excitation 
of fluorophores immobilized on the surface of the fiber and not those in the bulk 
sample, reducing potential noise. Extensive research on evanescent wave 
fluoroimmunoassays has been conducted at the US Naval Research Laboratory 
resulting in the commercialization of the portable RAPTOR system available from 
Research International. The RAPTOR allows four samples to be analyzed in parallel, 
with a 10min assay time, and has been used to detect waterborne pathogens at 
concentrations such as 5x10
4
 G. lamblia cysts/mL (54), 10
5
 C. parvum oocyst/mL 
(55), 10
4
 CFU/mL of E. coli O157:H7 (57) and 10
3
 CFU/mL of S. enterica Enteritidis 
(58) and fecal indicators, like enterococci, in environmental samples at 10
5
 CFU/mL 
(56). 
 
Biosensors employing the signal amplification and noise reducing techniques 
described can benefit, or have benefited, from the increases in sensitivity commonly 
achieved with microfluidics or microfabricated sensor elements. As a result of 
working on a dimensional scale closer to the size of the microbial and viral pathogens 
found in water, limits of detection nearing single cell may be possible. For example, 
with devices employing antibody-coated, 200nm diameter polypyrrole nanowires 
individually suspended between two electrodes to create a field-effect transistor, 
Shirale et al. detected down to 1 PFU/L of an enterovirus surrogate in urban runoff 
water (83). The binding of virions to the surface of the nanowire produces a 
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measurable change in increase in resistance as the close proximity of negative 
moieties of the analyte depletes available charge carriers in the bulk of the wire. This 
effect is measurable for such a low virus concentration due to the nanoscale 
dimensions of the sensor (84). 
Improvements for DNA-based biosensors 
Nucleic acid biosensors already provide the desired sensitivity for detecting 
waterborne pathogens present at low concentrations, with some reporting single 
organism limits (52, 85). The primary area to focus improvement efforts necessary for 
these biosensors is the overall assay time required to realize detection in real samples. 
Starting with environmental water samples requires, first, the purification and 
concentration of the pathogen of interest, followed by steps to disrupt the cell 
membrane, oocyst wall, spore coat, or viral capsid and purify the genetic material 
prior to amplification and detection. Clearly defined protocols and commercially 
available kits exist for these tasks, such as Dynal’s IMS kits and beads and Qiagen’s 
nucleic acid purification line of products. These pre-processing steps, while necessary, 
add time. Thus, investigations to shorten, eliminate, or provide alternatives to these 
methods.  
 
Many pre-processing methods can benefit from miniaturization. Confining a reaction 
within a micro or nanoscale fluidic channel has great potential to decrease assay time 
as the smaller volume reduces diffusion limitations (86) as well as simplify assay 
procedures by stringing multiple operations together into micro Total Analysis 
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Systems (µTAS) (87). Microfluidic devices for some sample preparation steps have 
already been reported, including immunoseparation and pre-concentration as discussed 
previously, as well as for mRNA isolation (88), PCR (39, 89-94) and isothermal 
amplification reactions (95).    
 
As is the case with immunosensors, methods that improve the analytical sensitivity are 
also of interest. However, as PCR-based methods already allow for low limits of 
detection with respect to numbers of pathogenic organisms, methods that can provide 
similar limits without amplification should be the primary focus. This promises to 
reduce both assay time and complexity. Bio-barcode assays, for example, have been 
used to produce signal amplification as Zhang et al. demonstrated in an assay for S. 
enterica Enteritidis. Here, gold nanoparticles coated in a target-specific probe and 
fluorescein-labeled barcode DNA in a 1:100 ratio were used along with magnetic 
beads in a sandwich hybridization assay capable of detecting 0.25 fmol of target 
DNA(96). This is similar to the limits achieved when using the aforementioned 
liposomal signal amplification in DNA-based sensors(78, 97). However, this is not 
sensitive enough by itself for detection of unamplified target. Using multiple 
liposome-tagged probes in a lateral flow assay, Nugen et al. selected bacterial 16S 
rRNA as a potential target as 80% of the total RNA in a cell is rRNA (98). This assay 
was capable of detecting 135ng of total bacterial RNA without enzymatic 
amplification in only 20 minutes (99), demonstrating the future promise of liposome-
based signal amplification.  
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Another method that has proven capable of yielding specific signals in assays without 
enzymatic amplification is up-converting phosphor technology (UPT). Using 
inorganic microcrystals which emit visible light when excited by an infrared laser, 
UPT can produce specific signals with very low background due to a lack of 
autofluorescence (100). With PCR amplification, assays using these reporter 
molecules were capable of detecting 3 amol of specific target DNA (101). Zuiderwijk 
et al. employed 4 probes, 2 labeled with biotin for capture of the desired target and 2 
labeled with digoxigenin, and UPT-reporter molecules labeled with an anti-digoxigen 
antibody (102). With the assistance of the multiple probes, this assay was capable of 
detecting 1ng of genomic DNA, or approximately 10
6
 bacterial cells.  
Conclusion 
Waterborne pathogens represent a critical, global health problem and methods that can 
rapidly, sensitively, and specifically detect their presence in accordance with water 
safety regulations and clinically significant levels are imperative for the improvement 
of the health and quality of life for millions of people. While DNA biosensors have 
proven effective at detecting low concentrations, they typically require time 
consuming purification processes upstream. Immunosensors require relatively fewer 
sample processing steps, thus less time. Through various signal amplification and 
background noise reduction techniques, coupled with the improvements in sensitivity 
promised by miniaturization, antibody-based detection methods have great potential 
for rapid, sensitive analysis of all forms of waterborne pathogens. 
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Current and future research efforts need to be focused on the detection of pathogens 
from their actual environmental matrix and on the needed pre-processing steps. This 
includes miniaturization strategies, materials research, and an emphasis on 
multiplexing so that ideally all relevant pathogens for a specific scenario can be 
detected at once. Taken together, this will produce novel methods capable of 
providing the necessary sensitivity, specificity and speed to replace the current 
standards and, hopefully, improve access to safe drinking water and decrease the 
global health burden of waterborne disease.  
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CHAPTER 2 
 
HUMAN PATHOGENIC CRYPTOSPORIDIUM SPECIES BIOANALYTICAL 
DETECTION SYSTEM WITH SINGLE OOCYST LIMIT OF DETECTION 
 
Abstract 
A bioanalytical detection method for specific detection of viable human pathogenic 
Cryptosporidium species, C. parvum, C. hominis, and C. meleagridis is described. 
Oocysts were isolated from water samples via immunomagnetic separation, and 
mRNA was extracted with oligo-dT magnetic beads, amplified using nucleic acid 
sequence-based amplification (NASBA), and then detected in a nucleic acid 
hybridization lateral flow assay. The amplified target sequence employed was a 
portion of the hsp70 mRNA specific to the pathogenic species, production of which is 
stimulated via a brief heat shock. The described method was capable of detecting one 
oocyst in 10 μL using flow-cytometer-counted samples. Only viable oocysts were 
detected, as confirmed using 4′,6-diamidino-2-phenylindole and propidium iodide 
(DAPI/PI) staining. The detection system was challenged by detecting oocysts in the 
presence of large numbers of common waterborne microorganisms and packed pellet 
material filtered from environmental water samples. When the method was compared 
with EPA Method 1622 for C. parvum detection, highly comparable results were 
obtained. Since the described detection system yields unambiguous results within 4.5 
h, it is an ideal method for monitoring the safety of drinking water.   
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Introduction 
Cryptosporidium is a waterborne protozoan parasite, several species of which can 
cause cryptosporidiosis, an intestinal disease in humans and domestic mammals. In 
immunocompromised or immunosuppressed patients cryptosporidiosis can be fatal. 
Three species are known to cause infection in humans; C. parvum, C. hominis and C. 
meleagridis have all been implicated as the causative agents in the infection of 
humans, regardless of immunological status (1, 2). Outbreaks of cryptosporidiosis 
have occurred on a worldwide basis from various contaminated sources, with the 
largest outbreak occurring in 1993 in Milwaukee, Wisconsin with over 400,000 people 
infected and over 100 deaths after contamination of the municipal water supply (3). 
More recently, in August 2005, about 4,000 people were infected with 
Cryptosporidium at the Seneca Lake State Park in Geneva, New York, after 
chlorinated recreational water became contaminated. An estimated 300,000 cases of 
cryptosporidiosis occur each year in the United States resulting in approximately 66 
deaths (4). Most commonly used water treatment methods, i.e. chlorination, are 
ineffective in the prevention of transmission of Cryptosporidium as part of the 
parasite’s life cycle is a resilient oocyst phase. Although the number of oocysts often 
found in contaminated water is generally very low, a volunteer study showed that 10 
oocysts could cause illness in healthy people (5) and the FDA suggests that as few as 
one oocyst could cause infection.  Therefore, a sensitive diagnostic method is 
necessary for effective detection. 
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Detection of Cryptosporidium in public water treatment systems relies on the EPA-
approved Method 1622 (6). This method requires filtration and immunomagnetic 
separation of oocysts from the resuspended captured material. Captured oocysts are 
then stained using fluorescein-isothiocyanate conjugated anti-Cryptosporidium species 
monoclonal antibody as well as a nucleic acid stain to determine oocyst concentrations 
via fluorescence microscopy. This method, however, is unable to discriminate between 
species pathogenic or nonpathogenic to humans. Furthermore, Method 1622 can not 
distinguish between viable and, therefore, pathogenic oocysts and non-viable, non-
pathogenic oocysts. These shortcomings can lead to false positive results. Additional 
staining methods need to be applied in order to obtain additional information on the 
viability of the oocysts. Alternatively, excystation of the oocysts or infectivity assays 
can be performed, but they require additional expertise, are extremely time consuming 
and labor intensive. Thus they are not suitable for  routine water analysis (7, 8). 
 
As only viable oocysts can cause infection, detection of only these oocysts is 
desirable. Messenger RNA (mRNA) is a short-lived and often inducible molecule and 
is optimal for distinguishing viable from non-viable organisms. In this study, a mRNA 
for a heat shock protein, hsp70, common to C. parvum, C. hominis, and C. meleagridis 
was chosen as the target sequence (9). As an mRNA for a heat shock protein, this 
molecule will be produced in large amounts when the oocysts are subjected to elevated 
temperatures; we will show this mRNA is only produced in viable organisms.  
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Lateral flow sandwich assays using dye-encapsulating liposomes as a signal 
amplification system have been well established. Previously, nucleic acid 
hybridization-based sandwich assays using liposome technology have been reported 
for the detection of pathogenic organisms including B. anthracis (10), Dengue virus 
(11), and E. coli (12). These assays are inexpensive, rapid, specific, and simple to run.  
 
Previously, we have reported the detection of C. parvum via its hsp70 mRNA using an 
electrochemiluminescence assay that demonstrated the specificity and potential for the 
development of a much simpler C. parvum assay system. Since then, we have also 
reported the use of a competitive liposome-lateral flow assay that was not as sensitive 
as other LFAs for other nucleic acid sequences using sandwich hybridization (13). 
Fritsch and colleagues have reported the detection of C. parvum via the same RNA 
using an electrochemical micro-vessel sensor (14). In the present work, we have 
integrated immunomagnetic separation directly into the assay and optimized the C. 
parvum detection using oligo-dT mRNA isolation. We have proven the extreme 
sensitivity of the assay using flow-cytometer counted samples of C. parvum and have 
proven that the assay can detect all human-pathogenic Cryptosporidium species. 
Finally, we compared the detection system with EPA Method 1622.  
 
Materials & Methods 
Several kits were used in this study, including the Dynabeads® mRNA DIRECT 
Micro Kit and the Dynabeads® anti-Cryptosporidium Kit from Dynal Biotech, a 
division of Invitrogen Corporation (Frederick, MD). Also used was the NucliSens® 
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Basic Kit amplification reagents to perform the NASBA from bioMérieux, Inc 
(Durham, NC). All phospholipids and cholesterol where obtained from Avanti Polar 
Lipids, Inc. (Alabaster, AL), streptavidin, sulforhodamine B (SRB) were purchased 
from Invitrogen Corporation. Polyethersulfone test strip material was purchased from 
Pall Corporation (Port Washington, NY) and nitrocellulose test strip material was 
obtained from Hanomy, LLC (Cheshire, CT). All oligonucleotides were ordered from 
Operon Biotechnologies (Huntsville, AL). Crypt-a-Glo™ FITC-labeled antibody was 
purchased from Waterborne, Inc. (New Orleans, LA). 
 
Stock solutions of C. parvum oocysts used in this study were  provided by Clancy 
Environmental Consultants, Inc. (St. Albans, VT) and were from the Iowa isolate 
maintained at Waterborne, Inc. All samples of oocysts counted by flow cytometry 
were provided by the Wisconsin State Laboratory of Hygiene (Madison, WI). C. 
hominis oocysts were provided by Dr. Giovanni Widmer and C. meleadgridis oocysts 
were provided by Dr. Sal Tzipori, both of the Tufts University School of Veterinary 
Medicine (North Grafton, MA).  C. muris oocysts were also obtained from 
Waterborne, Inc., via Clancy Environmental Consultants, Inc. Both samples of 
Giardia intestinalis and Oocystis minuta were provided by Clancy Environmental 
Consultants, Inc. as well as all packed pellet material from environmental water 
samples. Escherichia coli O157:H7 was purchased from ATCC, number 43888.  
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Immunomagnetic Separation (IMS) 
Some alterations were made to the use of the Dynabeads® anti-Cryptosporidium Kit, 
in that recommended volumes were halved. Thus, 5 mL sample volumes were used 
and 500 µL each of SL™-A and SL™-B buffers were added. Fifty microliters of anti-
Cryptosporidium IMS beads were added to each tube and incubated for 90 minutes at 
room temperature under constant rotation. Each tube was then placed in a magnetic 
particle concentrator (MPC) for two minutes and the supernatant aspirated. The bead-
oocyst complex was resuspended in 500 μL 1X SL™-A buffer and transferred to a 
sterile nuclease-free 1.5 mL Eppendorf tube. The tubes were allowed to stand in the 
MPC with the magnet in place for two minutes.  The supernatant was aspirated from 
each tube and the magnet removed.  Samples being processed through the Dynabeads 
mRNA DIRECT Micro Kit were then resuspended in 100 µL nuclease-free water. 
 
Heat Shock, Lysis, and mRNA Isolation 
One-hundred microliter oocyst samples were heat shocked at 42°C for 20 minutes. 
The oocysts were then lysed by a freeze thaw process (15) consisting of five cycles of 
freezing in an ethanol/dry ice bath and thawing in a 65°C water bath, with each 
treatment lasting for one minute. 
 
The samples were processed using the Dynabeads® mRNA DIRECT Micro Kit for 
isolation of mRNA using oligo-d(T)25 superparamagnetic beads as per the 
manufacturer’s directions. Briefly, the samples were mixed with 100 µL of a 
Lysis/Binding Buffer, containing 100 mM Tris-HCl pH 7.5, 500 mM LiCl, 10 mM 
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EDTA pH 8.0, 1% lithium dodecyl sulfate (LiDS) and 5 mM dithiothreitol prior to 
lysis and mixed with 20 µL of an oligo-d(T)25 bead solution by pipetting. The solution 
was gently shaken, to prevent settling, at 23°C for five minutes before being placed on 
a magnetic stand and supernatant aspirated. The beads were then washed by twice 
adding and aspirating 100 µL of Wash Buffer A, containing 10 mM Tris-HCl pH 7.5, 
0.15 M LiCl, 1 mM EDTA, 0.1% LiDS, and twice adding and aspirating 100 µL Wash 
Buffer B, containg 10 mM Tris-HCl pH 7.5, 0.15 M LiCl, 1 mM EDTA. Finally the 
beads were resuspended in 5 µL of nuclease-free water. 
 
NASBA Procedure 
NASBA was conducted using the NucliSens® Basic Kit amplification reagents as per 
the manufacturer’s instructions in a final volume of 20 L. Briefly, 10 µL of the 
Reagent Mix, including 2 pmol per reaction of each of the primers shown in Table 2.1, 
were added to the 5 µL samples containing the resuspended oligo-d(T)25 beads and 
incubated at 65°C for five minutes and then at 41
o
C for five minutes. Five microliters 
of the Enzyme Mix was then added and the samples were returned to the 41°C heat 
block for five minutes. Samples were then transferred to a 41°C water bath for a 90 
minute incubation. The primers used in these experiments have previously shown to 
be extremely sensitive and specific for the detection of C. parvum (9). 
Table 2.1: NASBA Primers 
Component 5’→ 3’ Concentration 
Primer 1 aat tct aat acg act cac tat agg gag aag gta gaa cca cca acc aat aca 2.0 pmol/assay 
Primer 2 aga ttc gaa gaa ctc tgc gct ga 2.0 pmol/assay 
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Lateral Flow Assay 
One microliter of NASBA product was aspirated from the sample, still containing the 
oligo-d(T)25 beads, and mixed with 2 µL of liposomes tagged with the reporter probe 
shown in Table 2.2, prepared as previously reported (16), and 5 µL of hybridization 
buffer, containing 20% formamide, 4X SSC, 0.2% Ficoll type 400 and 0.125 M 
sucrose, and allowed to incubate at 41°C for 20 minutes. A lateral flow test strip with 
the capture probe (Table 2.2) immobilized was inserted into the tube and after the 
mixture migrated into the test strip an additional 35 µL of the running buffer was 
added to complete the assay. Signals were then read at the capture zone and a 
background reading was taken just below this zone using an ESECO handheld 
Biosmart Reflectometer BR-10, λ = 560 nm (Cushing, OK). Capture and background 
readings were subtracted to yield the final signals. The probes used in this assay have 
previously shown to provide sensitive and specific detection of C. parvum (9). Test 
strips were prepared as previously described using a Camag Linomat IV for consistent 
application of the streptavidin-capture probe solution (11, 17), with 60 pmol of 
biotinylated capture probe and 20 pmol of streptavidin immobilized on each test strip. 
A positive signal is defined as a reflectometer reading at the capture zone that is more 
than 5 above the background reading, with any sample yielding a difference less than 
this considered to be negative. 
Table 2.2: Probes for Detection 
Probe 5’→ 3’ 
Reporter gtg caa ctt tag ctc cag tt –cholesterol 
Capture biotin-aga ttc gaa gaa ctc tgc gc 
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Verification of Viability Detection with DAPI/PI Staining 
A stock sample containing 5.9x10
4
 oocysts of C. parvum per 100 μL was split to 
provide 4 aliquots of 1 mL each in screw-top, gasket-sealed microcentrifuge tubes. Of 
these aliquots, 2 were placed in boiling water for a total of 15 minutes, removed every 
5 minutes to vortex. All 4 samples were then allowed to rest at room temperature for 
72 hours to allow any hsp70 mRNA produced at the early stages of boiling to degrade. 
 
One boiled sample and one control sample were centrifuged at 12,000 rpm for 1 
minute in a microcentrifuge and the supernatant was aspirated, leaving the pellet and 
less than 50 μL of the supernatant. One milliliter of acidified Hanks’ Balanced Salt 
Solution (HBSS), pH 2.75, was added to the samples and they were allowed to 
incubate at 37°C for 1 hour. The samples were centrifuged as before, the supernatant 
removed and 1 mL of normal HBSS added to resuspend the pellet. This wash step was 
then repeated and the sample was centrifuged and the supernatant aspirated once 
again, and the pellet was resuspended in 100 μL of normal HBSS.  
 
To each sample, 10 μL of 2 mg/mL DAPI in methanol and 10 μL of 1 mg/mL PI in 
1XPBS, pH 7.2 were added. The samples were then incubated in the dark for 90 
minutes at 37°C. Seven microliters of a 1X working solution of Crypt-a-Glo™ FITC-
labeled antibody was added to each sample and it was allowed to incubate for another 
30 minutes at 37°C. Upon removal from incubation 1mL of normal HBSS was added 
to each sample and mixed by vortexing. 
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Slides were prepared by placing 5 μL of a sample on each slide and covering with a 18 
mm
2
 coverslip, which was then sealed with clear nail-polish. Samples were then 
examined at 600X using the appropriate filters and DIC optics in order to classify 
oocysts based on inclusion or exlusion of DAPI and PI, and visualization of the 
contents of the oocysts as shown in Table 2.3. 
 
Table 2.3: Correlation of Viability to Staining and DIC Visualization 
Type of Oocyst Viability Status 
PI+ Dead 
DAPI+/PI- Viable at Assay 
DAPI-/PI- Viable with further trigger 
Cytoplasmic DAPI+/PI- Dead 
Ghost Dead 
 
 
Boiled samples were to be examined until a minimum of 200 oocysts were counted 
and non-boiled control samples were examined to confirm the presence of viable 
oocysts.  
 
These samples were then compared to the corresponding boiled and non-boiled 
samples which where heat shocked and lysed as described. The samples were then 
diluted from the original oocyst concentration to 10 oocysts per 100 μL and divided 
into 100 μL aliquots prior to mRNA isolation, amplification and detection as 
described. 
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Preparation of Environmental Water Samples 
Environmental water samples were filtered as per method 1622 and all material 
captured on the filter was eluted and collected by Clancy Environmental Consultants, 
Inc. Each sample was characterized based on biological and inorganic contaminants, 
as shown in Table 2.4. Some of the samples were shipped containing formalin. In 
order to wash out any formalin, each of the environmental water samples were 
centrifuged for 20 minutes are 1,200xg, the supernatants were removed, and the 
packed pellet volume estimated. Each sample was then diluted to 5% packed pellet 
volume prior to being split into replicates. Environmental water samples were spiked 
into tubes containing 100 oocysts of C. parvum in 500 µL nuclease-free water sorted 
by flow cytometry and the total volume was brought to 5 mL with nuclease-free water 
providing packed pellet volumes of 1 to 4.5% per replicate. 
Table 2.4: Characteristics of Environmental Water Samples 
Sample ID Source Type Water Type 
Equivalent 
Volume (L) 
Percentage 
Pellet Volume 
per Replicate 
Characteristics 
256-6 River Source ~ 6 4.5% 
Algae, diatoms and vegetative 
debris – typical river water 
201-1 River Source 34 1% 
High concentration of algae, 
diatoms, rotifers, free-living 
protozoa and vegetative debris 
094-3 River/Reservoir Raw 10 4.5% 
Very high levels of biological 
particles and inorganic debris 
243-2 Lake Source 102 2.5% High in algae and Diatoms 
270-3 Well Source 4690 3.5% 
High inorganic debris. Low in 
biologicals 
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Results & Discussion 
Detection of Human Pathogenic Cryptosporidium spp. 
Samples containing 0, 5, 25, 50, 100, 250, and 500 oocysts of C. parvum, C. hominis, 
or C. meleagridis, respectively in 100 µL of nuclease-free water were prepared and 
heat shocked, lysed and the mRNA isolated as described above. The samples were 
then amplified via NASBA and the samples quantified using the lateral flow assay. All 
three species were successfully identified at concentration levels as low as 5 oocysts 
(Table 2.5). Since samples were generated via serial dilution from a stock solution 
containing 5 x 10
3
 oocysts/mL, the oocyst concentrations shown here are not as 
accurate as those performed later. However, the data demonstrate that all three human-
pathogenic species of Cryptosporidium can be detected with the biosensor assay using 
the same primers and detection probes.  
Table 2.5: Percentage of samples testing positive at varying oocyst 
numbers for the three human pathogenic Cryptosporidium species 
†
 
Number of Oocysts C. parvum C. hominis C. meleagridis 
0 0% 0% 0% 
5 67% 100% 33% 
25 100% 100% 67% 
50 100% 100% 100% 
100 100% 100% 100% 
250 100% 100% 100% 
500 100% 100% 100% 
    
† Six replicates were tested for each number of oocysts for each species. 
 
 
Initial experiments employed total RNA isolation using the Qiagen RNeasy Mini Kit. 
However, as the target molecule is mRNA and Cryptosporidium is eukaryotic, mRNA 
isolation using oligo-d(T)25 magnetic beads was also investigated and found to be 
better due to the more specific isolation of mRNA molecules via their poly-A tail and 
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elimination of potentially contaminating rRNAs and tRNAs. Thus, this procedure 
yielded more consistent results, especially at low oocyst concentrations and was 
employed in all experiments described here. 
 
Specificity for Human Pathogenic Cryptosporidium 
Eight samples containing 500 oocysts of C. muris in 100 µL of nuclease-free water 
were treated as described above and amplified with a negative control and a positive 
control, a sample containing mRNA isolated from 500 oocysts of C. meleagridis. The 
negative control as well as all eight samples containing oocysts of C. muris produced 
negative signals on the lateral flow test strips while the positive control generated a 
strong positive signal at the capture zone. This indicated that no false positive signals 
will be generated by non-human pathogenic C. muris.  
 
Detection in the Presence of Contaminating Organisms 
Samples containing 10 oocysts of C. parvum and approximately 5 x 10
4
 cells of E. coli 
O157:H7, Giardia intestinalis, or Oocystis minuta, respectively in 5 mL were 
processed using the IMS procedure described above. The samples were then heat 
shocked, lysed, isolated, and amplified as described above. Each combination of 
contaminating organism and C. parvum were analyzed in quadruplicate and compared 
to samples containing 10 oocysts of C. parvum aliquoted from the same stock run in 
parallel.  
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The samples containing C. parvum oocysts and contaminating organisms tested 
positive in all cases, as shown in Figure 2.1. One sample out of 4 containing only 10 
oocysts of C. parvum yielded a negative result. It is assumed that either this sample 
was not handled correctly, or that less than 5 viable oocysts were present since 
samples were generated via dilution only.  
 
 
Figure 2.1: Cryptosporidium Detection in the Presence of Contaminating Organisms.  
Each sample was analyzed in quadruplicate and contained 10 oocysts of C. parvum. Those 
containing G. intestinalis or O. minuta had 54,000 cells and samples with E. coli O157:H7 had 8.6 
x 10
4
 CFU. 
 
Analytical Sensitivity 
Samples containing 1, 2, 3, 4, 5 or 10 oocysts of C. parvum in 10 µL counted into 
tubes by flow cytometry were obtained from the Wisconsin State Laboratory of 
Hygiene. Prior to shipping, these samples were heat shocked as described and 100 µL 
of the Lysis/Binding Buffer from the Dynabeads mRNA DIRECT Micro Kit were 
added prior to lysis. This buffer contains 5 mM dithiothreitol, an RNase inhibitor, 
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which should increase the stability of the target hsp70 mRNA. Samples were then 
shipped on dry ice and upon arrival all samples were thawed. RNA was isolated, and 
amplified as previously described. As shown in Figure 2.2, all 8 of the samples 
containing 1 oocyst of C. parvum scored positive. Additionally, all 8 replicates 
containing 2, 3, 4, 5 and 10 oocysts scored positive; indicating that our assay is 
capable of detecting a single oocyst. 
 
Sample Test Strip Visual Signal 
Negative Control  
 
- 10 
1 oocyst + 29 
1 oocyst + 30 
1 oocyst + 17 
1 oocyst + 34 
1 oocyst + 23 
1 oocyst + 26 
1 oocyst + 19 
1 oocyst + 19 
Positive Control + 22 
    
Figure 2.2: Lateral flow test strips from 1 oocyst C. parvum samples 
Samples containing 1 oocyst of C. parvum were prepared by flow cytometry and 
processed through heat shock, lysis, mRNA isolation and NASBA amplification yielding 
obvious signals.  
 
 
Discrimination between Viable and Non-viable Oocysts 
Upon examining the boiled sample, 315 oocysts were counted all of which score 
DAPI-/PI+ with no oocysts scoring in any other category, yielding a 0% viable score. 
Examination of the control sample yielded 50 oocysts scoring DAPI+/PI-, with the 
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DAPI staining localized to the nuclei indicating that there are in fact viable oocysts in 
the control. As staining was only to confirm the presence of viable oocysts, counting 
was limited to this category even though DAPI-/PI- oocysts could be viable. It should 
be noted that during counting no PI+ oocysts were noted, though there were several 
DAPI- oocysts observed. Examples of the stained oocysts from both samples are 
shown in Figure 2.3. 
 
Boiled Sample 
a. 
 
b.
 
Control Sample 
c.
 
d.
 
 
Figure 2.3: DAPI/PI Viability Staining Results 
The images from the boiled sample show a cluster of 6 oocysts stained with the (a) FITC-labeled 
antibody on the oocyst wall and (b) PI inclusion in the cytoplasm. It is evident from the FITC-
labeled antibody (a) that there is deformation of the oocysts common in dead oocysts, note the 
brighter locations indicating crumpling of the oocyst walls. The control sample yielded viable 
oocysts; shown (c, d) are two different oocysts that showed DAPI staining localized to the nuclei. 
A DAPI- oocysts can be seen (d) next to a DAPI+ oocyst. 
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From both the boiled and the control non-boiled samples, 24 aliquots of 10 oocysts per 
100 μL were processed through mRNA isolation and NASBA along with 3 positive 
and 3 negative controls. All 24 aliquots from the boiled sample provided no signal, 
correlating to the 0% viability assessed via DAPI/PI staining. Also, all 24 aliquots of 
the control non-boiled sample yielded positive signals, which also correlates to the 
observed viable oocysts via DAPI/PI staining.  
 
Comparison to EPA Method 1622 
Samples containing nominally 10 oocysts or 25 oocysts of C. parvum were prepared 
and half were processed through the IMS, staining and enumeration procedures of 
EPA Method 1622 by Clancy Environmental Consultants, Inc. (6). The remaining 
samples were heat shocked, had 100 µL Lysis/Binding Buffer added, and where lysed 
via the previously described freeze/thaw procedure. These samples were then shipped 
frozen, thawed and mRNA isolated and amplified via NASBA prior to being 
quantified using the lateral flow assay. The actual concentration of the samples was 
determined by staining and counting additional samples from the same IMS 
procedure, as would normally be done at the end of  Method 1622 (6); the actual 
concentration was 4 to 11 oocysts for those labeled to contain 10, and 17 to 32 oocysts 
for those labeled to contain 25. 
 
The results shown in Table 2.6 indicates that the detection system described here is 
highly comparable to EPA Method 1622. While it cannot provide quantitative results, 
i.e. only a yes/no answer, it is very rapid, easy to perform and does not require 
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expensive equipment, aside from a freezer and a heating bath. The signal values 
obtained with the biosensor were lower than expected when compared to all previous 
analyses. We assume that either the oocysts were not all viable that were contained in 
the sample (thus reducing the number of detectable oocysts for the biosensor close to 
or below the detection limit), or that the two-step detection process in which samples 
were shipped frozen prior to RNA extraction and amplification resulted in partial loss 
of RNA in the samples.  
Table 2.6: Comparison of results obtained from experimental method and EPA 
Method 1622 for samples containing 10 or 25 oocysts of C. parvum 
Testing Method Sample ID 
Signal or  
Oocyst Count 
Interpretation 
Experimental 
Method 
10 A 8 Positive 
10 B 30 Positive 
10 C 37 Positive 
25 A 12 Positive 
25 B 12 Positive 
25 C 0 Negative 
Method 1622 
10 D 11 oocysts Positive 
10 E 9 oocysts Positive 
10 F 10 oocysts Positive 
25 D 17 oocysts Positive 
25 E 10 oocysts Positive 
25 F 24 oocysts Positive 
 
Spiked Environmental Water Samples 
All four replicates of the control sample, consisting of 100 counted oocysts in 5 mL of 
nuclease-free water, yielded positive signals as did all four replicates of samples 201-
1, 243-2, 270-3, 256-6, and 094-3. This result, shown in Figure 2.4, all samples tested 
yielding positive results – indicates that the system described can be used to detect 
viable C. parvum oocysts in concentrated pellet material from environmental water 
samples following IMS.  
50 
 
Sample Test Strip Signal 
Negative  
 
- 
Control + 
Control + 
Control + 
Control + 
201-1 + 
201-1 + 
201-1 + 
201-1 + 
Positive + 
Negative 
 
- 
243-2 + 
243-2 + 
243-2 + 
243-2 + 
270-3 + 
270-3 + 
270-3 + 
270-3 + 
Positive + 
Negative - 
256-6 + 
256-6 + 
256-6 + 
256-6 + 
094-3 + 
094-3 + 
094-3 + 
094-3 + 
Positive + 
   
Figure 2.4: Lateral Flow Test Strips for Environmental Water Samples 
Samples containing 100 oocysts counted by flow cytometry were spiked with packed 
pellet material in a total volume of 5 mL and processed through IMS. All samples 
yielded positive signals 
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Conclusions 
Employing IMS, heat shock, freeze–thaw lysis, mRNA isolation, NASBA 
amplification and a nucleic acid hybridization lateral flow sandwich assay, the 
described method specifically detects as few as one oocyst of a viable human 
pathogenic Cryptosporidium species. Assuming a single oocyst present in a 5 mL 
sample is captured by IMS, the described method would hence be capable of detecting 
one oocyst per 5 mL as proven here. In addition, because large environmental water 
samples were filtered and used as sample matrix, we can safely assume that one oocyst 
captured through filtration and IMS from large samples (hundreds to thousands of 
liters of water) can indeed be detected with this method. Detection of these oocysts is 
possible in the presence of large numbers of microorganisms commonly found in 
contaminated water samples and in packed pellet material collected from 
environmental water samples. The entire method, from IMS to readable signals on the 
test strips, takes only 4.5 h with IMS running 90 min, a 20-min heat shock, 10 min for 
freeze–thaw lysis, 5 min for mRNA isolation, 115 min for NASBA (including steps 
prior to incubation), a 20-min liposome-target hybridization incubation, and 10 min 
for the lateral flow assays to produce signals. Most importantly, results obtained with 
the method compared very well with those from EPA Method 1622. 
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CHAPTER 3 
 
INTEGRATED MICROFLUIDIC PRE-CONCENTRATOR AND 
IMMUNOBIOSENSOR 
 
Abstract 
We present a microfluidic biosensor that integrates membrane-based preconcentration 
with fluorescence detection. The concentration membrane was fabricated in 
polyacrylamide by an in-situ photopolymerization technique at the junction of glass 
microchannels. Liposomes entrapping sulforhodamine B (SRB) dye molecules were 
used for signal amplification. The biotin-streptavidin binding system was a model 
system for evaluating device performance. Biotinylated liposomes were 
preconcentrated at the membrane by applying an electric field across the membrane. 
The electric field causes the liposomes to migrate towards the membrane where they 
are concentrated by a sieving effect. Two orders of magnitude concentration was 
achieved after applying the electric field for only 2 min. The concentrated bolus was 
then eluted towards the detection unit, where the biotinylated liposomes were captured 
by immobilized streptavidin. The integrated system with the preconcentration module 
shows a fourteen-fold improvement in signal as opposed to a system that does not 
include preconcentration. 
 
Introduction 
Microfluidic systems have become increasingly popular in biological and chemical 
analyses owing to the advantages of minimal reagent use, cost-effectiveness and 
automation (1, 2). An important application of microfluidic systems has been in the 
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field of biosensors for pathogen detection and clinical diagnostics (3-5). However, the 
use of microfluidic devices for the total analysis of a whole sample has been limited 
due to the challenges associated with integration of the different processing steps like 
sample preparation, preconcentration, analysis and detection on the same device (6-
10). In this paper, we present an integrated microfluidic immunobiosensor that 
combines preconcentration and fluorescence detection steps to enable sensitive 
detection in dilute samples.  
 
Pre-concentration of sample prior to analysis is an important step in microfluidic 
systems as it enables detection of very small concentrations of analytes and also 
improves detection sensitivity and signal-to-noise ratios. A number of pre-
concentration techniques have been developed that can achieve high concentration 
factors in small time durations. Some examples include surface-binding techniques 
like solid-phase extraction (11-13) and electrokinetic manipulation techniques like 
isoelectric focusing (14-16), field-amplified sample stacking (17, 18), isotachophoresis 
(19-21) and dielectrophoresis (22, 23). However, the limitations of these techniques 
are that they either involve buffer handling challenges or fabrication complexities 
making them difficult to integrate with lab-on-chip systems. Porous membrane-based 
pre-concentration systems, on the other hand, do not require complex buffer systems 
to concentrate samples. Khandurina et al. (24, 25) demonstrated the use of a porous 
silicate membrane while Wang et al. (26) used a nanofluidic filter for pre-
concentration. However, in the former case, the authors reported that the silicate 
membranes were hard to fabricate in a reproducible manner and the latter approach 
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involves the fabrication of micro- and nanochannels in the same device. More 
recently, Kim et al. (27) have developed self-sealed nanoporous junctions inside 
PDMS microchannels for pre-concentration. However, PDMS-based devices are less 
robust than glass-based microfluidic devices and are prone to surface adhesion and 
reusability issues. 
 
We use an in-situ photopolymerized nanoporous membrane (28-30) in our integrated 
glass microfluidic device for the pre-concentration step. Song et al. (28) have shown 
high concentration factors (four orders of magnitude local concentration) using these 
nanoporous membranes. The in-situ fabrication technique allows for easy integration 
with total analysis systems. Our membranes are fabricated in polyacrylamide as it is 
hydrophilic, biocompatible and shows minimal non-specific adhesion (30). The pore-
size of acrylamide gels can be easily adjusted by changing the percentage of monomer 
components (31, 32). Moreover, unlike other membrane-based concentration methods, 
the response of this system is linear with the voltage-time product (28). 
 
Figure 3.1 shows the integrated microfluidic biosensor with the inset showing the 
concentration membrane. The membrane is nanoporous and is made using 
polyacrylamide at the intersection of the glass channels by an in-situ 
photopolymerization technique (28-30). We use liposomes, which can encapsulate a 
very large number of fluorescent dye molecules in their core for signal amplification 
in the biosensor. Fluorescence from the dye molecules is quenched when they are 
encapsulated at a high concentration within the liposome core. The analytes to be 
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detected are tagged with liposomes (33) and these complexes are injected into the inlet 
well of the device. An electric field is applied across the membrane, causing the 
liposome-analyte complexes to migrate towards the membrane. However, since the 
size of the pores in the membranes is much smaller than the size of these complexes, 
they are concentrated at the membrane by a sieving effect. The concentrated bolus is 
then eluted towards the detection region, where these complexes are captured using 
immobilized antibodies. The captured liposomes are then lysed by flowing a detergent 
and the released fluorophores result in a significant signal enhancement due to the 
elimination of self-quenching of the dye molecules. 
 
Figure 3.1: Image of the integrated glass microfluidic device used for the biotin-streptavidin 
experiments, with the channels filled with food dye to appear dark and show contrast.  The inset 
shows a picture of the polyacrylamide membrane-based concentrator at the junction of 
microchannels. Biotinylated liposomes are captured by streptavidin-conjugated magnetic beads 
localized at the magnet. The fluorescence from the lysed liposomes is imaged downstream from 
the magnet in the region marked as the fluorescence measurement window. 
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In this paper, we present results showing improved detection sensitivity with the 
inclusion of the pre-concentration system using proof-of-concept experiments 
performed with biotin-streptavidin binding.  
 
Experimental Methods 
Fabrication of microfluidic channels 
Schott D263 glass wafers (100 mm diameter, 0.55 mm thick; S I Howard Co., 
Worcester, MA) were used for etching microfluidic channels. Device geometry was 
defined using L-Edit CAD software (Tanner Research) and a photomask was created 
using GCA/Mann 3600F Optical Pattern Generator. A 225 nm thick layer of 
amorphous silicon deposited on the glass wafers by PECVD was used as the hard 
mask for etching. The wafers were then coated with a 3 µm thick layer of Shipley 
1818 positive photoresist and soft-baked at 115°C for 1 min. The mask pattern was 
transferred to the photoresist using an EV 620 contact aligner and the wafers were 
developed using a 300MIF resist developer. The exposed silicon was etched using an 
Oxford 80 (#1) reactive ion etching (RIE) system and the photoresist was stripped 
using a mixture of acetone and isopropanol. The exposed glass was etched using a 
16% HF solution (Shape Products Company, Oakland, CA). The glass wafers were 
exposed to HF for 14 min, resulting in channel depths of 20 µm (etch rate of D263 
glass in 16% HF is about 1.4 µm/min when left unagitated). Finally, the remaining 
silicon on the wafers was removed by reactive ion etching using the Oxford 80 (#1) 
system. In the final device, the wide channel width was 120 µm and the narrow 
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channel width was 50 µm. The depths of the channels in both cases were 20 µm. 
Connection holes were made in the wafers by sandblasting. 
  
Wafer bonding 
The glass microchannels were sealed by a plain borofloat glass wafer (100 mm 
diameter, 500 µm thick; Mark Optics, Santa Ana, CA) using a low temperature glass 
bonding technique (24, 25, 34, 35). The etched and the plain glass wafers were 
cleaned by sonicating in acetone for about 5 min. The wafers were then hydrolyzed in 
RCA cleaning solution (prepared by mixing 5N ammonium hydroxide, 30% w/w 
hydrogen peroxide and deionized water in 3:2:9 ratio by volume) for 20 min at 70-
80°C, rinsed in deionized water and dried under nitrogen. This was followed by 
plasma cleaning to activate the surfaces of both the wafers prior to bonding. A thin 
layer of potassium silicate (KASIL 2130, The PQ Corp., Valley Forge, PA) was 
coated on the plain glass wafer by spinning a diluted solution (1:10 by weight in 
deionized water) at 2000 rpm for 8 sec. As the spin-coated wafer was then brought 
into contact with the etched glass wafer, the bonding region spread instantaneously 
across the entire area of the wafers. The bonded wafers were then placed in a hot press 
at 90°C for an hour to reinforce the bonding.  
  
Membrane fabrication and surface treatment 
The channels of the bonded devices were treated with 1 M NaOH for 20 min to 
remove the potassium silicate layer in the microchannels. The wafers were then rinsed 
with DI water and dried in nitrogen. Prior to membrane fabrication, the glass channels 
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were coated with an acrylate-terminated self-assembling monolayer to enable covalent 
attachment of the polyacrylamide membrane to the channel walls (36-38). For this, the 
channels were prepared by exposing to 1 M HCl for 30 min, rinsing in DI water and 
then exposing to 1 M NaOH for 30 min. The channels were thoroughly rinsed with DI 
water and then exposed to a freshly mixed coating solution containing 2:3:5 mixture 
(by volume) of 3-(trimethoxysilyl)propyl acrylate, glacial acetic acid  and deionized 
water for exactly 30 min. The channels were finally rinsed in 1-propanol and DI water 
and dried with vacuum. 
 
The polyacrylamide membrane was fabricated at the intersection of the glass 
microchannels by a photopolymerization technique (28-30). For this, a 355 nm laser 
beam was shaped using a train of lenses and mirrors into a long narrow beam to match 
the dimensions of the channel junction. The optical train also helps to direct the beam 
through a microscope to enable visualization of the polymerization process. The 
channels were filled with a freshly prepared and degassed solution of 22% (15.7:1) 
acrylamide/bisacrylamide containing 0.2% (w/v) VA-086 photoinitiator (30). All the 
reservoirs were capped with tape to prevent evaporation, and the solution was allowed 
to equilibrate for 20 min to eliminate pressure-driven flow. The membrane was then 
fabricated by directing the shaped laser beam towards the junction and exposing for 
approximately 15 sec. The unpolymerized acrylamide solution was purged from the 
channels and the channels were rinsed thoroughly with DI water.  
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Finally, the channels were coated with linear polyacrylamide to suppress the 
electroosmotic flow (36-38). The channels were filled with a degassed solution of 50 
mg/ml acrylamide in deionized water containing 250 ppm hydroquinone and 2 mg/ml 
V-50 photoinitiator and exposed to UV light in a UV oven for 30 min. The 
unpolymerized solution was rinsed out of the channels and the channels were cleaned 
with DI water.  
 
Liposome and magnetic bead preparation  
Liposomes were prepared by a modified version (33) of the reversed-phase 
evaporation technique described by Siebert et al. (39). All lipids used were obtained 
from Avanti Polar Lipids (Alabaster, AL). Fluorescent liposomes encapsulate 150 mM 
sulforhodamine B (SRB) dye in 0.02 M HEPES, pH 7.5 in the core and also contain 
0.33 mol% dipalmitoyl phosphoethanolamine(DPPE)-rhodamine in the bilayer. 
Biotinylated lipids were used in the preparation of the liposomes in order to add 
functionality to the outer surface of the bilayer. The remainder of the bilayer consists 
of 35 mol% dipalmitoyl phosphatidylcholine (DPPC), 15 mol% dipalmitoyl 
phosphatidylglycerol (DPPG), 42 mol% cholesterol, and 6 mol% N-(glutaryl)-1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine. After formation of the vesicles, 
extrusions through 1 µm and 0.4 µm filters was performed to assure unilamellar 
liposomes with a uniform size distribution. Removal of unecapsulated SRB was 
facilitated by application of the liposome preparation to a Sephadex G-50 column 
equilibrated with 0.01 M HEPES, 0.2 M NaCl, 0.2 M sucrose, 0.01% sodium azide 
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(NaN3), pH 7.5 (1X HSS), also used for elution. Fractions containing liposomes were 
collected and dialyzed 1X HSS in the dark overnight. 
 
To capture these biotinylated liposomes in the microfluidic device, commercially 
available streptavidin-conjugated superparamagnetic beads (Dynabeads MyOne 
Streptavidin, 1 μm in diameter; Invitrogen, Carlsbad, CA) were used. Prior to use, the 
stock was vortexed to homogenize the suspension and the necessary volume was 
removed. In order to remove preservatives and introduce the working buffer, the beads 
were then washed twice with an equal volume of 1X HSS by applying the tube to a 
magnet rack, removing the supernatant, and resuspending. 
 
Sample loading, concentration and detection  
Prior to performing concentration and detection experiments, the channels of the 
device were primed with 1X HSS buffer. A permanent magnet was positioned on the 
top surface of the device upstream of the detection region using adhesive putty. One 
microliter of Dynabeads MyOne streptavidin-conjugated superparamagnetic beads 
prepared in 1X HSS buffer was injected towards the magnet through the port 5 
(Figure 3.1) using a syringe pump at a flow rate of 1 µl/min. For the electrokinetic 
concentration experiments, a solution of 10,000x diluted fluorescent liposomes 
(biotinylated with SRB dye in the core) in 1X HSS buffer was used. For the direct 
injection experiments, the liposome solution was further diluted by a factor of 10 in 
1X HSS buffer (due to lowest achievable flow rate limitations with our existing 
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equipment) so that the same number of liposomes is flowed through the device for 
performance comparison.  
 
For the direct injection experiments, the biotinylated liposome solution in 1X HSS 
buffer was injected towards the magnet with a syringe pump at a flow rate of 10 µl/hr 
for 90 sec through inlet port 1 (Figure 3.1). On the other hand, for the electrokinetic 
concentration experiment, all the wells were filled with 60 µl of plain 1X HSS buffer 
except the inlet well which was filled with the liposome-1X HSS solution. The 
pressure driven flow in the system was eliminated by adjusting the heights of the 
solutions in the wells. The liposomes were then electrophoretically concentrated at the 
membrane by applying a voltage difference of 150 V across the membrane. After 
concentrating for a duration of 90 sec, the concentrated bolus of liposomes was eluted 
towards the bead bed by applying a voltage of 150 V to the outlet port 3 downstream 
of the magnet. In both cases, after liposome injection, wash buffer was injected at a 
flow rate of 20 µl/hr to wash off any unbound liposomes in the device through port 5. 
A detergent solution of 60 mM octyl-β-D-glucopyranoside (OG) was then flowed 
through the same port 5 towards the bead bed at a flow rate of 40 µl/hr and the emitted 
fluorescence from the lysis of the liposomes was recorded downstream of the bead 
bed. 
 
For each experiment, the background was calculated as the average of the total 
fluorescence intensity values estimated in the region of interest during the first 60 
frames of the detergent injection videos. 
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After each run, the device was thoroughly rinsed with deionized water multiple times 
followed by a final rinse which involves flowing deionized water at a rate of 2 µl/min 
with a syringe pump for 15 min.  
 
Concentration factors during the experiments were estimated analytically as the ratio 
of the swept volume of liposomes at a given electrophoretic velocity to the volume of 
the measurement window around the membrane. The electrophoretic velocity of 
liposomes was estimated from Zetasizer measurements. 
 
Results  
Electrophoretic concentration of fluorescent liposomes 
Concentration and elution experiments were performed using fluorescent liposomes to 
estimate the concentration factors for the membrane-based pre-concentration system. 
Figure 3.2 shows snapshots of the channel junction during the concentration and 
elution steps achieved by switching electric fields between the vertical and horizontal 
channels. Figure 3.3 shows the concentration factor plotted as a function of time for 
which the high voltage is applied across ports 1 and 4 (Figure 3.2(a)). It can be seen 
from Figure 3.3 that after a concentration time of 160 sec, the estimated concentration 
factor was around 230. Analytical calculations (as described in the materials and 
methods section) resulted in concentration factors of around 350 for 160 sec of 
applying high voltage which is on the same order of magnitude as the experimental 
value. For these calculations, the zeta potential of the liposomes estimated from 
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Zetasizer measurements was -28.8 ± 2.9 mV (resulting in a mean electrophoretic 
velocity of 103.1 µm/sec), while the inferred zeta potential from the experiments was -
19 mV. The trend in Figure 3.3 is linear as expected since the liposomes migrate with 
a constant electrophoretic velocity. 
200 µm 200 µm
200 µm200 µm
 
Figure 3.2: Image sequence showing liposome concentration and elution. Microchannel edges 
have been drawn for clarity. The membrane has also been highlighted in (a). HV denotes high 
voltage (100 V), PV pinch voltage (40 V), Gnd ground. (a) Before loading (b) Sample 
concentration (c) After concentration (d) Sample elution. Pinch voltage is applied to minimize the 
diffusion of the sample away from the membrane. 
 
Figure 3.3: Concentration factors during liposome concentration as a function of time. The 
intensities were averaged over a measurement window (23 x 180 pixels) shown as a box in the 
inset. The concentration factors are consistent with analytical values estimated using a liposome 
zeta potential of -19 mV. 
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Integrated concentration and detection experiments 
Concentration and detection experiments were performed with the biotin-streptavidin 
binding system in the integrated microfluidic device. For these experiments, 
biotinylated fluorescent liposomes (with SRB dye in the core and bilayer) were used 
as the analytes to be detected. Streptavidin coated magnetic beads immobilized in the 
channels using a permanent magnet served as the capture region. The liposomes were 
electrophoretically concentrated at the membrane by applying a high voltage across 
the membrane. The concentrated bolus of liposomes was eluted by switching the 
electric field towards the bead bed where the liposomes are captured. Figure 3.4 
shows an image of the bead bed with the captured fluorescent liposomes. The unbound 
liposomes were washed away by flowing 1X HSS as wash buffer over the bead bed. 
The OG solution was then injected into the channels, resulting in the lysis of the 
bound liposomes. The released fluorescence from the liposomes was captured 
downstream in the region indicated as the fluorescence measurement window in 
Figure 3.1. Snapshots from the fluorescence burst during OG injection in the region of 
interest are shown in Figure 3.5.  
 
Figure 3.4: Fluorescent liposomes captured at the bead bed immobilized using a permanent 
magnet. 
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Figure 3.5: Snapshots of the fluorescence measurement window (shown as a box) during OG 
injection. (a): Background image before the start of injection. (b), (c), (d): Snapshots during 
fluorescence burst from the lysed liposomes during OG injection. 
 
Comparison of device performance with and without concentration 
In order to evaluate the effect of the pre-concentration step on the performance of the 
system, direct injection experiments were performed where the liposomes were 
injected towards the bead bed using a syringe pump bypassing the concentration step. 
The number of liposomes in the device was maintained the same for both sets of 
experiments – with and without the pre-concentration step.  
 
The total fluorescence intensity in the measurement window during OG injection was 
estimated from the captured videos of fluorescence burst and plotted as a function of 
time. These intensity profiles are shown in Figure 3.6(a). This figure shows data from 
both the electrokinetic concentration (shown in red) and direct injection (shown in 
blue) experiments. The area under these curves gives the integrated fluorescence 
intensities for each of these experiments. These integrated intensities for the 
electrokinetic concentration and direct injection cases are compared in Figure 3.6(b). 
This figure shows that the inclusion of the pre-concentration step increases the signal 
by a factor of 14. The increased signal is a result of a concentrated bolus of liposomes 
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flowing over the bead bed resulting in better capture efficiencies than in the case 
where a dilute solution of the same number of liposomes is flowed.  
 
 
Figure 3.6(a): Fluorescence intensity profiles from the bead bed during OG injection for the two 
experiments including the preconcentration step (shown in red lines) and excluding it (shown in 
blue lines). (b): Comparison of the effect of preconcentration on the integrated fluorescence 
intensities from the bead bed during OG injection. The data is reported as mean ± SD with n=3. * 
indicates p<0.05. 
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Discussion 
The detection sensitivity of the biosensor depends on the binding kinetics between the 
low concentration of an analyte and the surface immobilized biorecognition element. 
This process is usually diffusion-limited (40-42), and an increase in the local analyte 
concentration in the capture region greatly improves the binding kinetics. Singh and 
coworkers (8, 30) have used similar membrane-based preconcentrators in conjunction 
with microchip SDS-PAGE and electrophoretic immunoassays to show improved 
separation resolution and detection limits. Wang et al. (43) have shown 500-fold 
improvement in sensitivity (from 50 pM to sub 100 fM) and improved dynamic range 
of immunoassay detection using nanofluidic filter based electrokinetic 
preconcentrator. However, the improvement in sensitivity has been reported for 
molecular analytes like proteins and does not include any post-binding amplification 
steps.  
 
Our design and fabrication techniques are compatible for integrating electrochemical 
detection into the device. The device can be operated in electrochemical detection 
mode by patterning gold interdigitated electrodes downstream from the membrane and 
using electrochemical liposomes instead of fluorescent ones (44). The low temperature 
bonding technique is suitable for bonding etched glass wafers with gold-patterned 
wafers as it does not lead to delamination of the gold electrodes as seen in the 
conventional high temperature bonding techniques. Also, the core of the liposomes 
can be filled with electrochemical species such as potassium ferri/ferro hexacyanide 
molecules instead of fluorophores for detection. This straightforward extension to an 
71 
 
electrochemical system is advantageous as electrochemical detection methods offer 
several benefits over popularly used optical detection techniques. These include low 
capital cost for equipment, portability, low power requirement and absence of 
photobleaching issues (45, 46).  
 
Conclusion 
We have presented an integrated microfluidic biosensor that integrates on-chip 
concentration with liposome-based signal amplification on the same device. We have 
achieved two orders of magnitude concentration with the membrane-based system 
within 160 sec of applying high voltage across the membrane. The electric field can be 
switched to elute the concentrated sample bolus towards the detection region where it 
is captured efficiently at the immobilized bead bed. The inclusion of the pre-
concentration step results in a fourteen-fold improvement in the signal as opposed to a 
system without the pre-concentration step, when the same number of liposomes is 
introduced in both cases. The functionality of the membrane can be extended to a 
filtering device for removing small interfering particles that competitively bind to the 
target probes, further increasing the signal-to-noise ratio. The inclusion of the pre-
concentration system in the integrated device along with the post-binding 
amplification achieved using liposomes help to improve the limit of detection of the 
biosensor. By extending the biosensor operation to electrochemical detection format, 
we can build an inexpensive and portable system that can be used for pathogen 
detection.  
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CHAPTER 4 
 
MICRO-TOTAL ANALYSIS SYSTEM FOR VIRUS DETECTION: 
MICROFLUIDIC PRE-CONCENTRATION COUPLED TO LIPOSOME-BASED 
DETECTION 
 
Abstract 
An integrated microfluidic biosensor is presented that combines sample pre-
concentration and liposome-based signal amplification for the detection of enteric 
viruses present in environmental water samples. This microfluidic approach 
overcomes the challenges of long assay times of cell culture-based methods and the 
need to extensively process water samples to eliminate inhibitors for PCR-based 
methods. Here, viruses are detected using an immunoassay sandwich approach with 
the reporting antibodies tagged to liposomes. Described is the development of the 
integrated device for the detection of environmentally relevant viruses using feline 
calicivirus (FCV) as a model organism for human norovirus. In-situ fabricated 
nanoporous membranes in glass microchannels were used in conjunction with electric 
fields to achieve pre-concentration of virus-liposome complexes and therefore enhance 
the antibody-virus binding efficiency. The concentrated complexes were eluted to a 
detection region downstream where captured liposomes were lysed to release 
fluorescent dye molecules that were then quantified using image processing. This 
system was compared to an optimized electrochemical liposome-based microfluidic 
biosensor without pre-concentration. The limit of detection of FCV of the integrated 
device was at 1.6 X 10
5
 PFU/mL an order of magnitude lower than that obtained using 
the microfluidic biosensor without pre-concentration. This significant improvement 
demonstrates that the integrated device has the potential to serve as an early screening 
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system for viruses in environmental water samples as it can serve as pre-concentrator 
and pre-purification step for a highly sensitive rapid immunoassay. 
 
Introduction 
Enteric viruses are any one of over 100 species that infect humans or animals via the 
fecal-oral route and primarily infect and replicate in the gastrointestinal tract. 
Although these viruses are commonly associated with gastroenteritis, they can cause a 
range of diseases, including respiratory infections, hepatitis, conjunctivitis, and 
meningitis (1). They have even been linked to chronic diseases like insulin-dependent 
diabetes (2).  
 
Once infected, humans or host animals shed virus particles in feces. Enteric viruses are 
then introduced into water systems mostly through leaking sewage and septic systems, 
urban and agricultural runoff, and directly from untreated or under-treated wastewater. 
Outbreaks have been linked not only to contaminated drinking water, but also 
contaminated recreational and irrigation water as well as shellfish harvested from 
contaminated waters (3). These pathogenic viruses are highly resistant to changes in 
pH and temperature, as well as to common methods of wastewater treatment. It has 
been shown that these viruses can remain infective for up to 130 days in seawater, 120 
days in freshwater and sewage, and 100 days in soil (1). Depending on the source of 
contamination and water supply in question, virus particles can be present in low 
concentrations, complicating both detection and sterilization methods. 
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Current detection methods for enteric viruses can be divided into two main categories: 
cell culture assays and molecular methods. The cell culture technique was the most 
popular method for detection of enteric viruses prior to the development of the 
Polymerase Chain Reaction (PCR) and remains the method of choice to isolate and 
determine infectivity of viruses. The cell culture technique requires the inoculation of 
a cell line, chosen based on the virus of interest, and incubating for days to weeks as it 
is evaluated for the cytopathogenic effects of a viral infection (4). This long incubation 
time is an obvious drawback of the cell culture assay, though it is not the only one; 
some viruses do not grow on established cell lines, grow too slowly, or just do not 
show any visible cytopathogenic effects.  
 
The molecular methods most commonly used for the detection of enteric viruses are 
variations of conventional PCR (5) or reverse transcriptase-PCR (RT-PCR) (6), 
including real-time PCR (7) and multiplex PCR (8), as well as Nucleic Acid 
Sequence-Based Amplification (NASBA) (9). These methods allow for the rapid, 
sensitive, and specific detection of enteric viruses of interest. The primary drawback to 
these molecular methods is the inability to limit detection to only infective viruses. 
However, this can be remedied by the use of integrated cell culture RT-PCR. This 
method involves inoculating a cell line with the sample and incubating for a short 
time, usually far before cytopathogenic effects are evident. Nucleic acids can then be 
extracted from the culture and processed through RT-PCR, testing for viral mRNA 
that would be produced only if the sample contained infective viruses. This process 
can, however, decrease the efficiency of detection (10).  
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As some enteric viruses are not cultivable and molecular techniques sacrifice 
efficiency of detection for an ability to identify infective viruses, many countries, 
including the United States, rely on indicators of fecal contamination - enterococci, 
coliform bacteria - rather than direct testing. Reliance on these indicators is flawed, as 
viruses are more resistant to disinfection processes and natural environmental 
conditions (11, 12). 
 
Feline calicivirus (FCV) is a member of the caliciviridae family that causes 
respiratory and potentially severe systemic disease in cats. FCV is used as a model for 
human pathogenic noroviruses, as it is a member of the same family as these viruses 
but is non-pathogenic to humans (13). Enzyme-Linked Immunosorbent Assays 
(ELISAs) for the detection of FCV have been previously described , which use either 
two antibodies (14) or one  antibody and one transmembrane glycoprotein (15). 
Detection limits were not reported, as the developed ELISAs were used to screen 
antibodies (14) or determine the binding domain of the glycoprotein (15). However, 
methods have been reported employing Atomic Force Microscopy (AFM) and 
Surface-Enhanced Raman Spectroscopy (SERS) for detection of FCV with limits of 
detection of 3 million and 1million virions/mL, respectively (16). 
 
Biosensors are an attractive detection method for molecules and small particles, such 
as virions, as they can produce rapid, sensitive and specific signals (17-22). Both 
microfluidic and lateral flow assays using liposome nanovesicles as a visual or 
electrochemical signal generation and amplification system have been well-established 
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using nucleic acids (17-22) and antibodies (23-25) as capture molecules, depending on 
the target being detected. Additionally, novel biological recognition elements have 
been employed in similar assays, such as using ganglioside-incorporating liposomes 
for the detection of cholera toxin subunit B (26).  
 
The often-low concentration of virions in water samples can be a challenge (11). 
Addressing this, herein described is the use of a microfluidic device combining pre-
concentration and fluorescent detection, previously described (27), to detect FCV. As 
shown in Figure 4.1.a, pre-concentration of the virus particles can be achieved by first 
allowing liposomes tagged with specific anti-FCV antibodies to bind, and then 
actuating the complexes toward a nanoporous membrane via electrokinesis (27, 28). 
These complexes can then be eluted from the membrane as a bolus and applied to a 
downstream capture and detection zone, where the non-specifically bound liposomes 
may be washed away prior to lysis and signal quantification. This was compared to an 
optimized microfluidic electrochemical detection assay, outlined in Figure 4.1.b, in 
which all incubation steps are conducted off-chip, in suspension. 
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Figure 4.1: Schematic of Assays with and without Pre-concentration.  
The assay employing electrokinetic pre-concentration (A) begins with loading the device with 
anti-FCV pAb-labeled Protein A superparamagnetic beads to create a capture bed and 
incubating the anti-FCV mAb-labeled fluorescent liposomes with FCV. The sample is then loaded 
into the inlet well, concentrated at the nanoporous membrane and eluted toward the capture bead 
bed. Following washing, detergent is injected to lyse the liposomes, releasing the fluorescent dye 
for quantification. The assay without pre-concentration (B) begins with incubating an FCV 
sample with the same capture beads as before. The virus-bead complexes are washed and 
incubated with electrochemical liposomes. This sample is pulled into the microfluidic channel, 
where the detection complexes are captured at a magnet andwashed and the bound liposomes are 
lysed with detergent. This releases the electroactive species, which undergoes redox cycling at a 
downstream IDUA. 
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Materials & Methods 
FCV purification and titration 
The F9 vaccine strain of FCV (ATCC; VR-782) was propagated on Crandell-Reese 
feline kidney (CRFK) cells (ATCC; CCL-94). Viral stocks were prepared from twice 
plaque-purified viruses. Purified FCV-F9 was prepared and titrated as previously 
described (29, 30), by extraction from cell lysates using trichlorotrifluoroethane 
followed by banding of virus on CsCl gradients (1.30 - 1.45 g/ml). Purified virus was 
dialysed into 150 mM NaCl, 10 mM Tris base, 15 mM MgCl2, pH 7.2 then stored at 
4°C prior to use. 
 
Biotinylation of antibodies 
Biotin was conjugated to antibodies using the EZ-Link® NHS-PEG4-Biotin kit and 
purified using the Slide-A-Lyzer® mini-dialysis kit (Pierce Rockford, IL). Briefly, 
100µL of 1mg/mL antibodies were added to the Slide-A-Lyzer tubes and dialyzed 
against 1X PBS, pH 7.0, to exchange the buffer and assure appropriate pH. Biotin was 
then added at more than a 20-molar excess to assure good conjugation at the relatively 
low antibody concentration, and the samples were incubated for 30 min at room 
temperature. The samples were again dialyzed against 1X PBS, pH 7.0, in order to 
remove the excess biotin. Samples were collected out of the dialysis tubes and stored 
in the refrigerator.  
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Preparation of capture beads 
Polyclonal anti-FCV antibodies (Baker Institute, Ithaca, NY) were purified from rabbit 
serum with a HiTrap Protein A HP column (GE Healthcare Uppsala, SE) as per 
manufacturer suggestions. Once purified, polyclonal antibodies were then conjugated 
to Protein-A magnetic beads from Dynabeads Immunoprecipitation kit (Invitrogen, 
Carlsbad, CA) as per manufacturer provided instructions.  
 
Preparation of streptavidin-conjugated liposomes 
Fluorescent streptavidin-conjugated liposomes were prepared via the reverse-phase 
evaporation method with 150 mM sulforhodamine B (SRB), 20 mM HEPES, pH 7.5, 
as the encapsulant as previously described (31) with modification. To allow for 
visualization of the liposomes during the concentration procedure, a fluorophore-
labeled lipid (Avanti Polar Lipids Alabaster, AL), 0.33 mol% 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl), was added to 
the initial lipid mixture. Liposomes coupled to streptavidin were incubated for 15 
minutes at room temperature with 1 µg anti-FCV monoclonal antibody (Abcam 
Cambridge, MA), biotinylated as above. The liposome-antibody conjugate was then 
diluted to a working phospholipid concentration of 0.7 mM. 
 
Liposomes with the same bilayer composition and streptavidin-modification were also 
prepared with an encapsulant of potassium ferri/ferrohexacyanide with a combined 
concentration of 200 mM for experiments using amperometric detection. These 
liposomes were prepared in 1X HEPES-Saline-Sucrose (1X HSS), containing 10 mM 
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HEPES, 200 mM NaCl, and 200mM sucrose, pH 7.5, but the liposomes were then 
dialyzed against 1X PBS, 20 mM sucrose, pH 7.5, as HEPES has been shown to 
interfere with electrochemistry (32, 33). 
 
Microtiter plate liposome immunoassay (LIA) for antibody selection 
Previously reported protocols for the use of liposomes in microtiter (34) were adapted 
and modified for virus detection. High-binding Nunc Maxisorb® polystyrene plates 
were prepared for a Liposome Immunoassay (LIA) by washing each well with 200 μL 
of 1X PBS. Anti-FCV antibodies were diluted with 1X PBS to 5 μg/mL and 200 μL 
were added to each well. The plates were then incubated overnight in the refrigerator. 
After incubation, wells were emptied, tapped dry, and washed with 200 μL of 1X 
PBS. Wells were blocked for 1 hour at room temperature with 200 μL of blocking 
reagents containing either 0.05% Tween-20 or 0.1% Tween-20 in 1X PBS. Plates were 
then emptied, dried and washed twice with 200 μL per well of 1X PBS. 
 
Prepared plates were then loaded with 100 μL per well of varying concentrations of 
FCV in 1X PBS in triplicate and incubated for 2 hours in the refrigerator with gentle 
shaking. Wells were tapped dry and washed twice with 200 μL of 1X PBS. 
Biotinylated anti-FCV antibodies were diluted in 1X PBS to a concentration of 1 
μg/mL, and 100 μL of solution was added to each well. Plates were incubated for 1 
hour at room temperature with gentle shaking. 
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The plates were washed twice in 200 μL per well of 1X HSS. Streptavidin-conjugated 
liposomes diluted to 50 μM phospholipids concentration and 100 μL were added to 
each well. Plates were again incubated for 1 hour at room temperature with gentle 
shaking. 
 
Plates were emptied, dried, and washed three times with 200 μL per well 1X HSS, 
respectively. For measuring the fluorescence emission at 590 nm, 50 μL of 30 mM 
octyl-β-D-glucopyranoside (OG) was added to each well. 
 
Concentration and Detection of FCV 
Prior to performing concentration and detection experiments, the channels of the 
device, shown in Figure 4.2, were primed with 1X HSS. A permanent magnet was 
positioned on the top surface of the device upstream of the detection region by use of 
adhesive putty. One microliter of polyclonal-antibody-conjugated superparamagnetic 
beads was injected towards the magnet through port 5 using a syringe pump at a flow 
rate of 1 µL/min. The packed bead bed at the magnet constitutes the capture region of 
the device. The liposome-antibody conjugate was then mixed with FCV of the 
required concentration and incubated for two hours. This virus-liposome solution was 
loaded into the inlet well of the device whereas all the other wells were filled with 1X 
HSS. The pressure-driven flow in the system was eliminated by adjusting the heights 
of the solutions in the wells. The virus-liposome complexes were then 
electrokinetically concentrated at the membrane by applying a voltage difference of 
150 V across the membrane. After concentrating for a 90 seconds, the concentrated 
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bolus was eluted towards the bead bed by applying a voltage of 150 V to the outlet 
port 3 downstream of the magnet. This results in the capture of the virus-liposome 
complexes at the bead bed, as illustrated in Figure 4.1. Wash buffer was injected at a 
flow rate of 20 µL/h to wash off any unbound liposomes in the device through port 5. 
A detergent solution of 60 mM OG was then introduced through the same port 
towards the bead bed at a flow rate of 40 µL/h and the emitted fluorescence from the 
lysis of the bound liposomes was recorded downstream of the bead bed. Video was 
captured during lysis, and the fluorescent intensity was integrated over time to yield 
the final signal. 
 
Figure 4.2: Combined Concentration and Detection Device.  
After the channels are filled with 1XHSS and the capture bead bed is packed at the magnet, a 
virus-liposome solution is introduced to port 1 and a potential is applied across the membrane 
(inset). Once concentrated, the virus-liposome bolus is eluted from the membrane by switching 
the potential to port 3, downstream of the magnet. Once the sample is captured, non-specifically 
bound liposomes are washed away by wash buffer, applied via port 5 using pressure-driven flow. 
Liposomes are then lysed using a detergent introduced through the same port. (Note: device filled 
with visible dye for illustrative purposes) 
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Detection of FCV without Electrokinetic Concentration 
To show the effect of pre-concentration on detection of FCV, the assay was also 
carried out in a microfluidic device outfitted with an interdigitated ultramicroelectrode 
array (IDUA) fabricated on polymethylmethacrylate (PMMA), shown in Figure 4.3, as 
previously described (35). The assay without electrokinetic concentration is similar to 
the procedure outlined above with several modifications required for the 
electrochemical transducer and pressure-driven flow. Streptavidin-conjugated 
liposomes encapsulating the ferri/ferrohexacyanide redox couple were substituted for 
those encapsulating SRB. To provide the most pertinent comparison, the procedure 
used was that which proved optimal for the device. Polyclonal antibody-conjugated 
Protein A superparamagnetic beads were prepared as described and 5µL were mixed 
with 70 µL of FCV in Dulbecco’s Modified Eagle’s Media (DMEM) with 10% fetal 
bovine serum (FBS) and incubated, gently shaking at room temperature for 10min. 
The sample was then applied to a magnet, separating the beads such that they could be 
washed twice with 75 µL 1X PBS, once with 75 µL 1X PBS with 0.2 M Sucrose (1X 
PBSS), and finally resuspended in 5 µL 1X PBSS. To this sample, 5 µL monoclonal 
antibody-coupled electrochemical liposomes were added and incubated, gently 
shaking at room temperature for 10 min. This sample was then pulled into the device, 
captured at the magnet and washed with 20 µL 1X PBSS at 5 µL/min to remove any 
unbound liposomes. Liposomes were then lysed, releasing the electroactive species to 
produce a signal, by the injection of 30 µM OG at 1 µL/min until the signal returned 
to baseline. Potential was applied and signals recorded using  an Epsilon 
Electrochemical Analyzer (BASi, West Lafayette, IN) as previously described (26). 
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Though using a different signal transduction method, previous work has shown 
detection limits on the same order of magnitude for fluorescent and electrochemical 
transduction (36). 
 
 
Figure 4.3: Device without pre-concentration module.  
The device, fabricated in PMMA has two microfluidic channels and IDUAs side-by-side for two 
separate samples. The sample is pulled into the device through the Outlet via negative pressure on 
the Buffer Inlet, allowing for the capture of the detection complexes at the magnet. The sample is 
then washed by buffer flow actuated via the Buffer Inlet and bound liposomes are lysed with the 
introduction of OG through the detergent inlet. Signals are obtained by applying a potential 
across the IDUA and recording the current resulting from the oxidation-reduction cycling of the 
electroactive encapsulant. 
 
Results & Discussion 
For the development of the integrated device for pre-concentration and detection of 
viruses, a standard immunoassay using liposome amplification was initially developed 
using a microtiter plate format. This was subsequently transformed to capture 
antibodies immobilized on superparamagnetic beads and implemented with 
fluorescent liposomes in the integrated device. Secondly, the assay was adapted to a 
microfluidic electrochemical biosensor using electrochemical liposomes as these have 
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been found to be as sensitive as fluorescent liposomes (36) and enable the 
development of portable and rapid microfluidic biosensors requiring little hardware 
(37). 
 
Selection of Antibodies and Assay Optimization 
A series of commercially available and custom antibodies were screened via the 
microtiter plate LIA described and a sample of highly-purified FCV in PBS. It was 
found that many antibody pairs would not result in effective capture and detection of 
FCV. Some pairs generated highly reproducible results and representative data of two 
combinations are shown in Figure 4.4; here, antibody pairs employing the polyclonal 
antibody as capture antibody generated high signals and signal-to-noise rations (SNR). 
Based on all combinations tried, it was determined that using a custom polyclonal 
rabbit-derived anti-FCV for capture was best in conjunction with the monoclonal 
labeled mAb1 (Abcam clone number FCV1-43) as it yielded an SNR just under 9 for a 
concentration of 5000 ng/mL. 
 
Further optimization of the assay employed FCV in lysed cell culture medium, 
containing DMEM with 10% FBS, and focused on blocking to reduce non-specific 
binding. A dose-response curve was developed for the microtiter LIA for future 
comparison to microfluidic devices, as shown in Figure 4.5. Here, the limit of 
detection is approximately 4x10
4 
PFU/mL. 
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Figure 4.4: Dose-response curves for polyclonal capture antibody with monoclonal reporter 
antibodies. The best antibody pair for the detection of FCV was determined by screening all 
variations in a microtiter plate liposome immunoassay (LIA). Here a custom polyclonal anti-FCV 
was immobilized to the plate and biotinylated anti-FCV monoclonal antibodies and streptavidin-
conjugated fluorescent liposomes were used for signal generation. 
 
 
Figure 4.5: Optimized assay for FCV detection in cell culture lysate.  
Using the previously optimized antibody pairs, FCV was detected in cell culture lysate consisting 
of DMEM and 10% FBS in a microtiter plate LIA. 
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Comparison of FCV detection with and without electrokinetic concentration: 
FCV detection experiments were performed to show the improvement in detection 
sensitivity with the inclusion of the electrokinetic pre-concentration step. In the first 
set of experiments, FCV was detected by use of the integrated microfluidic device that 
includes the pre-concentration step. Fluorescent liposomes were used in these 
experiments and the fluorescence intensity signal from the lysis of the captured 
liposomes was estimated using image processing. These experiments were done for 
different concentrations of FCV ranging from 0 – 6.0x105 PFU/ml. The limit of 
detection for these experiments performed with the integrated device was estimated, 
from the data shown in Figure 4.6, to be 1.6x10
5 
PFU/ml.  
Figure 4.6: FCV detection after electrokinetic concentration.  
FCV samples were incubated with anti-FCV-coupled liposomes for two-hours at the indicated 
concentrations. Samples were then concentrated for 90 sec by application of a potential across a 
nanoporous membrane and then eluted to the capture bead bed. After washing, liposomes were 
lysed with detergent and the fluorescence intensity downstream was integrated over time. 
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A second set of experiments were performed excluding the pre-concentration step by 
directly injecting the virus-liposome-bead detection complexes towards the magnet. 
Electrochemical liposomes were used in these experiments and the integrated current 
signal from the lysis of the captured liposomes is plotted as a function of the 
concentration of FCV as shown in Figure 4.7. The limit of detection in this case was 
estimated as 3.2 X 10
6 
PFU/mL, as it is more than 3 standard deviations above the 
negative control.   
 
Figure 4.7: FCV detection without pre-concentration.  
FCV samples were incubated with anti-FCV-coupled magnetic beads and anti-FCV-coupled 
liposomes for a total of 20 min, with wash steps, at the indicated concentrations. Samples were 
then injected into a microfluidic channel toward a magnet, where the detection complexes were 
captured and washed. Bound liposomes were lysed with detergent and the current measured 
across the IDUA resulting from the released electroactive species was integrated over time. 
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There is an order of magnitude improvement in the limit of detection with the 
integrated microfluidic device over the direct injection system as the increased 
concentration of the analytes improves the antibody-antigen binding kinetics in the 
detection region. This improvement is more remarkable as the direct injection device 
employed an optimized procedure allowing the magnetic beads, virus and liposomes 
to incubate, sequentially, off-chip in solution. This takes advantage of the bead surface 
area and should provide ample antibody-antigen interaction. Future planned 
experiments will include the addition of electrochemical detection into the integrated 
device in order to render it more field-portable. The equipment needed for 
electrochemical detection is relatively inexpensive, portable and can provide 
quantitative signal read-out making it better suited for on-site detection than the 
currently employed fluorescence-based detection described here (38).  
 
Current literature reports limits of detection of FCV on the order of 10
6 
particles/mL 
using Surface Enhanced Raman Spectroscopy (SERS) (39). Concentration is not easily 
converted from virus particles/mL to PFU/mL as they require the estimation of the 
infectivity, which is dependent not just on the particular strain but also the cell culture 
media and cell line. Based on an approximate ratio of infectious to non-infectious 
particles for enteric viruses in general (40), this corresponds to a limit of detection on 
the order of 10
4 
PFU/mL, which is comparable, though lower, than that reported herein 
. Although there have been strides in the miniaturization of SERS instruments, the 
equipment costs approximately $15,000 (41) and is best suited to laboratory analysis, 
particularly due to the approximately 20 hours of incubation time required for the 
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assay. Instead, the reported device, adapted for electrochemical detection, will be well 
suited to field portable assays due to its significantly shorter assay time of only xxx 
hours, small size, and comparable sensitivity. 
 
Most of the portable microfluidic biosensors for enteric virus detection reported in the 
literature are based on RT-PCR techniques (42-44). PCR is highly susceptible to 
inhibitors, primarily humic acid, that are present in environmental water samples, 
which can reduce sensitivity or completely inhibit the signal (45). Further, 
microfluidic PCR systems also face the challenges of adsorption of enzymes to 
channel walls (46), difficulty in precisely controlling temperature, sample evaporation 
and formation of bubbles in the channels (47). The advantage of our integrated 
microfluidic device is that it has on-chip detection times on the order of a few minutes 
and does not involve any temperature cycling issues.  
 
Conclusion 
Using a device integrating a liposome immunoassay with an upstream pre-
concentration of the virus-liposome complexes, we have shown a limit of detection of 
1.6 X 10
5
 PFU/mL for FCV. This detection limit is an order of magnitude lower than 
that obtained with an equivalent detection device that does not include pre-
concentration. The here described  system can be extended to electrochemical 
detection by patterning gold electrodes in the device and using electrochemical 
liposomes similar to those used in the described PMMA device. Electrochemical 
detection is inexpensive and portable with quantitative signal readout.  
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In addition, the current protocol described uses a concentration time of 90 seconds. 
His does by no means deplete the 60 µL sample of virus-liposome complexes. 
However, it was chosen as the high voltage employed coupled with the high 
conductivity of liposome diluent lead to resistive heating of the sample when longer 
times were used. In the future, we intend to avoid this problem by using several short 
pulses, sending several boluses of highly concentrated virus-liposome complexes to 
the capture bead bed. As significantly more liposome-virus complexes would end up 
concentrated on the membrane, we predict that this would result in a limit of detection 
decreased at least by an order of magnitude.   
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CHAPTER 5 
OPTIMIZATION OF MICROFLUIDIC ELECTROCHEMICAL DETECTION 
CHANNELS FOR LIPOSOME NANOVESSICLE-BASED SIGNAL 
AMPLIFICATION 
 
Abstract 
Microfluidic electrochemical biosensors for pathogen detection have been developed 
previously relying on liposome signal amplification. Here, liposomes entrap an 
electrochemically active redox couple and are tagged at their outer surface with DNA 
probes. In the assay, the liposome-coupled probe hybridizes to a nucleic acid target 
sequence, which in turn hybridizes to a second probe immobilized on a 
superparamagnetic bead via a sandwich approach. Bound target sequences are isolated 
in the capture zone via a magnet and subsequently quantified by lysing the liposomes 
using a detergent. Thus, the entrapped redox couple is released and measured on an 
electrode downstream of the magnet. Optimization of these systems was investigated 
leading to a dramatic decrease in the limit of detection achievable. First, the current 
measured by the interdigitated ultramicroelectrode array (IDUA) was enhanced via 
changes to the metal layers and assay buffer conditions. Second, the effects of the 
detection channel dimensions were investigated. It was found that a reduction in the 
channel height from 50µm to 20µm produced an order of magnitude reduction in the 
limit of detection of a DNA target sequence, a decrease from 0.1fmol to 0.01fmol per 
assay. This was due to the smaller volume into which liposomes were lysed and hence 
an overall increased concentration in the microfluidic channels.  Additionally, it was 
determined that too small dimensions resulted in too low volumetric flow rates and 
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prevented assay conduction as the superparamagnetic beads settled in the inlet hole. 
Thus, it is concluded that an optimal dimensional range can be identified striking the 
balance between increased limits of detection and successful execution of assay 
protocols under realistic time constraints.  
Introduction 
Microfluidic devices offer a number of advantages as a result of miniaturization, 
particularly the ability to analyze small sample volumes, integrate multi-step processes 
into one device, increased portability and potential for high throughput analysis. The 
pairing of microfluidics and amperometric detection is particularly advantageous as 
electrodes are readily miniaturized and the reduction in electrode size and spacing 
allows for the measurements of very low currents (1). 
For sensors employing electrochemical transduction that rely on liposome lysis for 
signal generation, the limit of detection for any analyte can theoretically be decreased 
by reducing the overall channel volume into which the liposomes are lysed. Since the 
liposomes contain a set concentration of the oxidation-reduction couple, lysing the 
same number in a smaller volume will produce a higher overall concentration of the 
electroactive species. Previous work determined that the lowest detectable 
concentration of potassium ferri/ferrohexacyanide in 0.1M phosphate buffer, pH 7.0, 
for a gold IDUA on Pyrex® glass consisting of two sets of 420 interdigitated fingers 
each being 2.5μm wide and high, separated by a 4.5μm gaps, is 0.5μM (2). Also as 
previously reported, liposomes extruded through 0.4μm pore polycarbonate filters 
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have been shown to be unilamellar and have a diameter of approximately 275nm (3). 
Assuming spherical geometry and that the combined concentration of the encapsulated 
redox couple is the same as the initial concentration added, 200mM, one can predict 
the concentration of liposomes needed to reach the limit of detection of 0.5μM. Here, 
that would be approximately 230 liposomes/nL. With the previously reported channel 
dimensions of 500μm wide and 50μm deep and assuming that the bead-target 
complexes are captured within the first 100μm of the magnet edge, 574 liposomes 
would need to be captured in order to produce a detectable concentration. It has also 
been established that increases in the height of the electrodes yield improved signals 
and signal-to-noise ratios, as the active surface of the IDUA is the gap face of the 
individual fingers, and 0.2M potassium phosphate is the optimal concentration of 
supporting electrolyte for detection of this redox couple using these electrodes (4). 
Based on these calculations, channels 500 and 50μm in width and 50 and 20μm deep 
were tested using a nucleic acid hybridization assay with a synthetic target that has 
been previously established (2, 5), in order to assess improvements in the analytical 
sensitivity.  
Materials & Methods 
All microfabrication was conducted at the Cornell NanoScale Science and Technology 
Facility (CNF), which also provided chemicals, silicon wafers, and consumables 
required for processing. Pyrex® borosilicate glass wafers were purchased from Mark 
Optics (Santa Ana, CA), Ultem™ macro-to-microfluidic connectors and PEEK™ 
tubing were purchased from LabSmith (Livermore, CA), polyimide-sheathed glass 
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capillary tubing was obtained from Polymicro Technologies (Phoenix, AZ), Tygon® 
tubing and thumb screws were purchased from Small Parts, Inc (Miami Lakes, FL), 
Sylgard® 184 silicone elastomer kit containing polydimethylsiloxane (PDMS) pre-
polymer and catalyst was procured from Dow Corning (Midland, MI), and Epo-Tek 
H20E conductive epoxy was purchased from Epoxy Technology Inc. (Billerica, MA). 
All experiments were carried out using a BASi Epsilon EC (West Lafayette, IN) and 
KD Scientific syringe pumps (Holliston, MA). 
Lipids used for liposomes were purchased from Avanti Polar Lipids (Alabaster, AL), 
all nucleotides were provided by Eurofins MWG Operon (Huntsville, AL), and 
Dynabeads® MyOne™ streptavidin superparamagnetic beads were purchased from 
Invitrogen (Carlsbad CA). All other chemicals were procured from VWR International 
(Radnor, PA). 
Fabrication of microfluidic channels 
Soft lithography was employed for the rapid prototyping of microfluidic channels (6) 
employing a channel design previously described (7). Briefly, a 100mm silicon wafer 
was patterned via standard photolithographic techniques and plasma etched using a 
Bosch process Unaxis 770. Prior to use, the remaining photoresist was stripped in a 
hot solvent bath (propylene glycol, N-methylpyrrolidone, tetramethylammonium 
hydroxide) and the master was treated with Rain-X® to create an anti-stiction coating. 
PDMS elastomer and catalyst were mixed 7:1, degassed, and 15mL was applied to the 
center of the silicon master, confined in a housing machined to exactly fit the wafer, 
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and cured for 1 hour at 80
o
C. Individual channels were pealed from the master, 
trimmed and ports were punched through to make the necessary connections. PDMS 
channel layers were sealed, reversibly, to a borosilicate glass slip patterned with an 
IDUA by sandwiching the device in a polymethylmethacrylate (PMMA) housing with 
pressure applied using thumbscrews as shown in Figure 5.1. Macro-to-microfluidic 
connections were made using ULTEM™ bonded port connectors for inlets and a 
PEEK™ tubing post at the outlet attached to the housing. The bottom portion of the 
housing includes a hole to accommodate a neodymium-iron-boron rare earth magnet. 
 
Figure 5.1: Fully assembled microfluidic device. The PDMS is reversibly sealed to a Pyrex® glass 
slip patterned with an IDUA such that the main channel passes over the electrode finger array. 
These layers are then sandwiched between two layers of PMMA, bearing the necessary ports for 
the introduction of sample, buffer, and detergent and removal of waste as well as the positioning 
of the magnet for bead capture. 
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Fabrication of IDUAs 
IDUAs were fabricated using standard projection photolithographic and lift-off 
techniques, as previously described (2), with modifications. Here, the metal stack 
consisted of a 10nm thermally evaporated chromium adhesion layer, 10nm e-gun 
evaporated platinum diffusion barrier and a 90nm thermally evaporated gold active 
electrode surface. A batch with the previously used stack, 7nm titanium adhesion layer 
and 50nm gold active layer, was also prepared. After lift-off, each electrode pair was 
diced to produce the necessary slips and copper leads were attached to the contact 
pads using electrically conductive silver epoxy. 
IDUA characterization 
To rapidly test the response of the electrodes to the redox couple, 10µL drops of 0.2M 
phosphate buffer, pH 7.0, and 10µM ferri/ferrohexacyanide in 0.2M phosphate buffer, 
pH 7.0, were applied to the IDUA fingers for 5min with an applied potential of 
400mV, washing with deionized water and drying under nitrogen flow between 
droplets. Recorded current was then averaged as the signal for each IDUA. 
IDUA flow response 
To determine the response of the IDUA to varying concentrations of the electroactive 
species, pulses of ferri/ferrohexacyanide in 0.2M phosphate buffer, pH 7.0, were 
flowed through the channels of varying dimensions for 10 minutes, long enough to 
reach a steady-state current response. The IDUA was connected to the potentiostat and 
a 400mV potential was applied across the two electrodes. 
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Liposome and magnetic bead preparation 
In this study, a synthetic DNA target based on the sequence of the hsp70 mRNA of 
Cryptosporidium parvum and the corresponding probes, developed previously, were 
used (8). Liposomes were made using the reverse phase evaporation method and 
cholesterol-tagged DNA oligonucleotide reporter probes as previously described with 
modifications (3). Here, the encapsulant was an equimolar 200mM potassium 
ferri/ferrohexacyanide in 20mM HEPES, pH7.5. These liposomes were prepared in 1X 
HEPES-Saline-Sucrose (1XHSS), containing 10mM HEPES, 200mM NaCl, and 
200mM sucrose, pH 7.5, and quantified based on phospholipid concentration via the 
Bartlett Assay (9, 10). As HEPES has been shown to interfere with electrochemistry 
(11, 12), an additional batch was made with an encapsulant of the same concentration 
of the redox couple but in 10mM sodium borate, 200mM NaCl, pH.7.5, and both 
batches were examined dialyzed against 1XHSS, 1XPBS, 200mM sucrose, pH7.5 
(1XPSS), and 1X Borate-Saline-Sucrose (1XBSS), containing 100mM sodium borate, 
200mM NaCl, 200mM sucrose, pH7.0, and lysed by mixing with 60mM n-octyl-β-D-
glucopyranoside (OG). 
Superparamagnetic beads coated in a monolayer of streptavidin were tagged with 
biotinylated oligonucleotide probes according to the manufacturer’s specifications. 
Briefly, 20µL of beads were washed twice in 2X Binding and Washing (B&W) 
Buffer, containing 10mM Tris-HCl, 1mM EDTA, 2M NaCl, pH7.5, and then 
resuspended in 18µL 1X B&W buffer and 2µL of 300µM biotinylated capture probe 
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and incubated for 15min, shaking at room temperature. The beads were then washed 
three times in 1X B&W buffer. 
DNA hybridization assay 
To assess the effect of channel dimensions on the analytical sensitivity of microfluidic 
biosensor assays with liposome-based signal amplification, a DNA sandwich 
hybridization assay was conducted. Per assay, 1µL of liposomes, 1µL of hybridization 
solution (20% formamide, 4X SSC, 0.2% Ficoll type 400, 0.8% dextran sulfate, 0.2M 
sucrose), 1µL capture beads, and 1µL target were mixed and incubated for 15min, 
shaking at room temperature. Each 4µL sample was drawn into PEEK™ tubing 
attached to a 1mL syringe filled with running buffer (20% formamide, 4X SSC, 0.2% 
Ficoll type 400, 0.2M sucrose) and then injected into the channels, maintaining a 
constant linear velocity of 20cm/min to avoid bead loss. The flow of running buffer 
was continued for 20µL to wash away any unbound liposomes, during which time a 
potential of 400mV was applied to equilibrate the system prior to the lysis of the 
liposomes via the injection of 30mM OG, 0.2M phosphate buffer, pH7.0 at a constant 
linear velocity of 6cm/min. Signals were recorded and the area under the curve was 
evaluated using OriginPro 8.5 (Northampton, MA). 
Results & Discussion 
Electrochemical microfluidic biosensors for pathogen detection have successfully used 
liposome amplification previously (2, 13-15). Though the IDUAs have been optimized 
for detection using ferri/ferrohexacyanide (4), until this point, no optimization of the 
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electrochemical detection had been performed as experiments were focused on the 
development of the microfluidic systems and the biological aspects of the assays. 
Here, we focused on the optimization of the electrochemical microfluidic assay by 
further investigating the fabrication of robust IDUAs and optimizing channel 
dimensions to best suit the bioanalytical assay involving liposome amplification. 
IDUA fabrication 
Previous work was conducted using IDUAs with a 7nm Ti adhesion layer and a 50nm 
Au layer (2). While many of the IDUAs worked well, they tended to become non-
functioning due to short circuiting, adhesion loss or large variability between 
electrodes even from the same wafer (34 - 43% CV) and between wafers (55% CV). 
We therefore investigated improving their performance by changing the metal stack 
and by further investigating supporting electrolyte solutions. The new metal stack 
consists of a 10nm Cr layer for adhesion and a 90nm Au layer for detection with a 
10nm Pt barrier layer in between to prevent the diffusion of Cr through the Au layer 
causing electrode failure (16). This resulted in highly stable IDUAs that could be re-
used for many analyses and also re-used in several microfluidic system set ups, i.e. 
PMDS-based devices could be dissembled and reassembled with the same IDUA. 
Also, the variability within one wafer and between wafers was significantly improved 
to 9 - 15% CV and 19% CV, respectively. Combining these new IDUAs with the 
increase from 0.1M phosphate buffer previously used (2) to the optimized supporting 
electrolyte concentration of 0.2M phosphate buffer (4), the signals increased from 47 
nA to 164 nA above the background signals. 
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Buffer optimization 
Liposomes are synthesized entrapping a highly concentrated solution of the 
ferro/ferrihexacyanide redox couple at 200 mM in buffer. In order to stabilize the 
entrapped solutions, liposomes are kept in a surrounding buffer solution with an equi- 
or slightly hyperosmolarity. However, phosphate buffer cannot be used for liposome 
synthesis as it prevents the ability to quantify liposome yields based on the Bartlett 
assay (10). Stabile liposomes encapsulating fluorescent dyes have been successfully 
produced using HEPES buffers with sucrose to balance the osmolarity (3, 10). To 
assure that this change from phosphate buffer would not hamper the signals obtained 
from the release of ferro/ferrihexacyanide from liposomes, signals obtained in various 
supporting electrolytes were investigated. Here, we studied 5µM 
ferri/ferrohexacyanide in phosphate, HEPES, and borate buffers and all were tested at 
supporting electrolyte concentrations of 0.01 and 0.1M and all but borate were 
evaluated at 0.2M. Borate buffer is saturated around 0.14M and it was tested at this 
concentration. It was found that 0.01M HEPES reduced the signal 60% with 
increasing concentrations eliminating the signal above background. The interference 
of HEPES and other Good’s buffers with electrochemical reactions has been 
documented (11), and in reactions with iron ions has been shown to stabilize the 
reduced form (12), which, here, would disrupt redox cycling generating a lower 
current. Further, saturated borate buffer provided the greatest improvement over 0.2M 
phosphate buffer, with over a 400% increase in signal.  
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With this knowledge, the synthesis of liposomes using HEPES or borate buffer, and 
subsequent dialysis against various buffers (1X HSS, BSS and PSS) was investigated 
in order to optimize subsequent electrochemical quantification.  
Figure 5.2: Effect of Encapsulant and Diluent Buffers on Liposome Performance. 
Liposomes made in either HEPES or borate buffers were dialysed against 1XBSS, 1XHSS, or 
1XPSS, mixed with 30mM OG and 8µL were applied to the fingers of an IDUA. Liposomes made 
in borate buffer generally performed better, and liposomes with HEPES encapsulant buffer 
performed best with HSS diluent buffer. 
Liposomes were lysed by mixing with 30mM OG and 8µL was applied to the fingers 
of an IDUA held at 400mV. As shown in Figure 5.2, the liposomes made in borate 
buffer generated signals higher than those of liposomes prepared in HEPES buffer. 
However, borate buffer liposomes were highly unstable and could not be synthesized 
reliably. Further studies were therefore continued with our traditional HEPES buffer 
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supported liposomes. Instead, we will include phosphate buffer in the OG detergent 
solution in order to further increase signal to noise ratios.  
IDUA electrochemical response with varying channel dimensions 
To determine the response of these IDUAs to the redox couple, dose-response curves 
were developed using these and microchannels of varying dimensions prior to 
experiments with the full hybridization assay. 
Maintaining a channel depth of 50µm, channels 500 and 50µm in width were 
assembled over the IDUAs. As shown in Figure 5.3, the wider channel produced 
consistently higher signals. However, the calculated detection limit for the 
concentration of the redox couple, based on a signal three times the standard deviation 
of the background, is approximately 0.2µM and 0.02µM ferri/ferrohexacyanide for 
500 and 50µm wide channels, respectively, as the narrower channel produced higher 
signal-to-noise ratios. For channels of the same width, here 500µm, but varying depth, 
either 50 or 20µm, produced similar signals as shown in Figure 5.4. This correlates to 
the fact that wider channels provide access to a greater surface area of the IDUA, 
allowing for more of the electroactive species to engage in redox cycling between the 
fingers of the array. 
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Figure 5.3: Calibration curve for 50µm deep channels of specified widths. Wider channels 
produce consistently higher signals; however, the narrower channels provide greater sensitivity 
due to the reduction in background noise (n = 3). 
 
Figure 5.4: Calibration curves for 500µm wide channels with specified depths. Channels of the 
same width with a varying depth produce the same signals as the active surface area of the IDUA 
is the same (n = 3). 
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Effect of dimension changes on DNA hybridization assay 
The true impact of the reduced channel volume over the IDUA is most clear when 
employing liposome signal amplification in the DNA hybridization assay. Flow rates 
for loading/washing and lysing of liposomes were previously optimized using a 
channel 500µm wide and 50µm deep (2). As the cross-sectional area of the detection 
channel decreases, the flow rate must also be reduced in order to control for linear 
velocity from channel to channel. The two flow rates required for the assay in the 
varying channels used are shown in Table 5.1.    
Table 5.1: Flow Rates Required for Equal Linear Velocities in 
Channels of Varying Cross-Sections 
Width (µm) Depth (µm) 
Flow Rate at 
20cm/min (µL/min) 
Flow Rate at 
6cm/min (µL/min) 
500 50 5.00 1.50 
500 20 2.00 0.60 
50 50 0.50 0.15 
 
Simply decreasing the depth of the channel from 50 to 20µm provides a significant 
enhancement in the limit of detection of the target DNA, as shown in Figure 5.5. The 
analytical sensitivity, calculated to be 3 standard deviations above the background 
noise, was approximately 0.1fmol of target DNA per assay for the 50µm deep 
channels. This was reduced to approximately 10 amol per assay for the 20µm deep 
channels. This is an improvement of an order of magnitude from simply decreasing 
the depth of the channel by 60%. Further decreasing the depth of the channel could 
lead to further improvements, however, the lower flow rates required to retain the 
beads, and not lose sample, could lead to clogging as the superparamagnetic beads 
have time to settle in the inlet. This was observed for the 50x50µm channels; bead 
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settling blocked the inlet, allowing for increase pressure and, ultimately, bonding 
failure and leakage. 
 
Figure 5.5: Dose-response curves for channels of two different depths using a DNA sandwich-
hybridization assay. The linear velocity of the detergent flow for liposome lysis was controlled for 
the varying depth (n = 3). 
 
Conclusions 
Improvements in the signal generation and transduction of the microfluidic 
electrochemical biosensor using liposomes were achieved by implementing optimal 
supporting electrolyte concentration, liposome dilutents and fabricating a thicker metal 
stack. Furthermore, reductions in the cross-sectional dimensions of a microfluidic 
channel positioned over an IDUA for electrochemical detection yielded a significant 
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decrease in the limit of detection of a model DNA hybridization assay employing 
liposome lysis for signal amplification. Channels 500µm wide were tested with two 
different depths, 50 and 20µm, yielding detection limits of 0.1fmol and 10 amol of 
target DNA per assay. Additionally, it was shown that, though current response to the 
redox couple was lower, signal-to-noise improvements were noted for narrower 
channels. The use of these channels in detection assays was, unfortunately, prohibited 
by the clogging of the sample inlet due to bead settling during loading at the low flow 
rate required to avoid bead loss at the magnet. This ultimately caused leakage as the 
backpressure disrupted the reversible seal of the device. To investigate the benefits of 
even smaller channels, permanent sealing of the device and improvements in bead 
capture will need to be investigated to permit higher flow rates. 
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CHAPTER 6 
CONCLUSION 
 
The work described in this dissertation focused on improvements to biosensor 
technologies to tackle two obstacles commonly faced in the detection of waterborne 
pathogens. These obstacles, namely low concentration of the analyte of interest and 
presence of contaminants in environmental matrices, must be overcome in order to 
produce a robust biosensor that is capable of detection at levels consistent with water 
quality regulations and with the clinically significant infectious doses that typically 
inform those regulations.  
The strategy presented for the detection of Cryptosporidium parvum successfully 
overcomes the presence of contaminants and low oocyst concentrations by the 
implementation, first, of immunomagnetic separation (IMS) and, second, a series of 
steps increasing specificity and sensitivity while further purifying, concentrating, and 
amplifying the target mRNA. This assay achieved the ultimate goal of extreme 
sensitivity – capable of detecting mRNA from a single oocyst – while still being able 
to process real environmental samples. Future work with this assay is the development 
of a micro-total analysis system (µTAS). 
Microfluidic devices have great promise not just for the reduction of user error but 
also increased sensitivity, reduced sample volumes and reagent costs, and novel and 
efficient pre-processing methods. Herein, work focused on integration of microfluidic 
nanoporous membrane pre-concentration with liposome-based detection and its 
application to enteric virus detection. The integration into one device of these two 
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modules provided improvements in the limit of detection. Nonetheless, the sensitivity 
needs further enhancement to reach levels competitive with other technologies. This 
may be achieved, in part, by implementing electrochemical detection and replacing 
magnetic bead-based capture with immobilized antibodies, which will reduce error 
associated with bead packing variability.  
Optimization of channel design and dimensions is crucial in microfluidic biosensor, as 
is demonstrated by the order of magnitude improvement in analytical sensitivity 
achieved simply by reducing channel height by 60%. This data can, and should, be 
used to seek further improvements in all microfluidic detection schemes reliant on 
lysis of liposomes for signal generation and amplification, including the described 
combined concentration-detection device. This, as well as reducing the distance 
between the nanoporous membrane and capture region to reduce diffusion of the 
bolus, will be crucial to future developments.  
Ultimately, the goal of biosensors for any analyte, including those for waterborne 
pathogens, is to provide a rapid, sensitive and specific result in as little time as 
possible with as little effort as possible. As discussed and demonstrated in the 
preceding chapters, there are trade-offs to be made when selecting how to detect a 
target – antibodies versus nucleic acid sequences, for example – that favor one 
criterion over another. The described system for detecting C. parvum targets a specific 
mRNA, permitting the detection of s single, viable oocysts. This does, however, 
sacrifice time as it requires a lengthy enzymatic amplification step. Research efforts 
should continue to pursue vigorously amplification-free nucleic acid sensors by 
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pursuing novel signal generation schemes, for example upconverting phosphors (UCP) 
and electrochemiluminescence (ECL), while harnessing the promise that 
miniaturization provides.  
With much focus on miniaturization, microfluidics and µTAS, one must not lose sight 
of real world needs. As we continually reduce the sample volumes that our devices can 
handle we must remember that regulations often require the testing of large samples. 
For instance, the US Environmental Protection Agency (US EPA) requires that at least 
100mL of drinking water be tested for the presence of fecal coliform as an indicator 
organism, a volume far greater than any microfluidic device can accommodate. It may 
seem attractive to simply divide large samples amongst several assays until the entire 
volume is processed. Doing so would require a method with high analytical sensitivity 
and a high-throughput, parallelized process, which may be attainable with microfluidic 
molecular biological techniques. However, this alone would not address the 
commonly present contaminates in these samples. Pre-concentration and purification 
methods are a must for any device that seeks to analyze real samples.  
Robust processing modules capable of handling larger samples via a combination of 
higher flow rates and larger volume channels and chambers should be pursued in order 
to realize the potential of microfludic biosensors. These should exploit the filtration 
and concentration methods currently employed on the macro-scale. For example, non-
specific concentration techniques, like charged filters are commonly used to retain 
pathogens of interest, particularly viruses, until elution for analysis and, as discussed 
in the preceding chapters, some have explored this on the micro-scale. Charged 
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nanofibers, beads/particles, or micro-patterned structures can increase surface area, 
provide increased capture efficiency, and should be further explored. However, water 
samples may easily foul a device, as sources may contain small rocks, occasionally 
consisting of iron ore complicating magnetic separations, clay colloids, and plant 
detritus. Thus, filter-based methods should always address fouling and best practices 
should call for designs that allow for possible backwashing or other means of assuring 
proper function during processing.  
